<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">EMBO Rep</journal-id>
<journal-id journal-id-type="iso-abbrev">EMBO Rep</journal-id>
<journal-id journal-id-type="doi">10.1002/(ISSN)1469-3178</journal-id>
<journal-id journal-id-type="publisher-id">EMBR</journal-id>
<journal-id journal-id-type="hwp">embor</journal-id>
<journal-title-group>
<journal-title>EMBO Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">1469-221X</issn>
<issn pub-type="epub">1469-3178</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27979975</article-id>
<article-id pub-id-type="pmc">5210159</article-id>
<article-id pub-id-type="doi">10.15252/embr.201642586</article-id>
<article-id pub-id-type="publisher-id">EMBR201642586</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>
<styled-content style="fixed-case">TLR</styled-content>3 downregulates expression of schizophrenia gene <italic>Disc1</italic> via <styled-content style="fixed-case">MYD</styled-content>88 to control neuronal morphology</article-title>
<alt-title alt-title-type="left-running-head">Chiung‐Ya Chen <italic>et al</italic></alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="embr201642586-cr-0001">
<name>
<surname>Chen</surname>
<given-names>Chiung‐Ya</given-names>
</name>
<xref ref-type="aff" rid="embr201642586-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embr201642586-cr-0002">
<name>
<surname>Liu</surname>
<given-names>Hsin‐Yu</given-names>
</name>
<xref ref-type="aff" rid="embr201642586-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="embr201642586-cr-0003">
<name>
<surname>Hsueh</surname>
<given-names>Yi‐Ping</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0866-6275</contrib-id>
<address>
<email>yph@gate.sinica.edu.tw</email>
</address>
<xref ref-type="aff" rid="embr201642586-aff-0001">
<sup>1</sup>
</xref>
</contrib>
</contrib-group>
<aff id="embr201642586-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Institute of Molecular Biology</named-content>
<institution>Academia Sinica</institution>
<named-content content-type="city">Taipei</named-content>
<country country="TW">Taiwan</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label>Corresponding author. Tel: +886 2 27899311; Fax: +886 2 27826085; E‐mail: <email>yph@gate.sinica.edu.tw</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>15</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>1</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>15</day>
<month>12</month>
<year>2016</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
<volume>18</volume>
<issue>1</issue>
<issue-id pub-id-type="doi">10.1002/embr.v18.1</issue-id>
<fpage>169</fpage>
<lpage>183</lpage>
<history>
<date date-type="received">
<day>20</day>
<month>4</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>08</day>
<month>11</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>09</day>
<month>11</month>
<year>2016</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2017 EMBO <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2016 The Authors. Published under the terms of the CC BY NC ND 4.0 license</copyright-statement>
<license license-type="creativeCommonsBy-nc-nd">
<license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution‐NonCommercial‐NoDerivs 4.0</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="file:EMBR-18-169.pdf" xlink:type="simple"></self-uri>
<abstract id="embr201642586-abs-0001">
<title>Abstract</title>
<p>Viral infection during fetal or neonatal stages increases the risk of developing neuropsychiatric disorders such as schizophrenia and autism spectrum disorders. Although neurons express several key regulators of innate immunity, the role of neuronal innate immunity in psychiatric disorders is still unclear. Using cultured neurons and <italic>in vivo</italic> mouse brain studies, we show here that Toll‐like receptor 3 (<styled-content style="fixed-case">TLR</styled-content>3) acts through myeloid differentiation primary response gene 88 (<styled-content style="fixed-case">MYD</styled-content>88) to negatively control <italic>Disrupted in schizophrenia 1</italic> (<italic>Disc1</italic>) expression, resulting in impairment of neuronal development. Cytokines are not involved in <styled-content style="fixed-case">TLR</styled-content>3‐mediated inhibition of dendrite outgrowth. Instead, <styled-content style="fixed-case">TLR</styled-content>3 signaling suppresses expression of several psychiatric disorder‐related genes, including <italic>Disc1</italic>. The impaired dendritic arborization caused by <styled-content style="fixed-case">TLR</styled-content>3 activation is rescued by <styled-content style="fixed-case">MYD</styled-content>88 deficiency or <styled-content style="fixed-case">DISC</styled-content>1 overexpression. In addition, <styled-content style="fixed-case">TLR</styled-content>3 activation at the neonatal stage increases dendritic spine density, but narrows spine heads at postnatal day 21 (P21), suggesting a long‐lasting effect of <styled-content style="fixed-case">TLR</styled-content>3 activation on spinogenesis. Our study reveals a novel mechanism of <styled-content style="fixed-case">TLR</styled-content>3 in regulation of dendritic morphology and provides an explanation for how environmental factors influence mental health.</p>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="embr201642586-kwd-0001">dendritic growth</kwd>
<kwd id="embr201642586-kwd-0002">dendritic spine formation</kwd>
<kwd id="embr201642586-kwd-0003">innate immunity</kwd>
<kwd id="embr201642586-kwd-0004">neonatal infection</kwd>
<kwd id="embr201642586-kwd-0005">neural development</kwd>
</kwd-group>
<kwd-group kwd-group-type="subject-categories">
<title>Subject Categories</title>
<kwd>Immunology</kwd>
<kwd>Molecular Biology of Disease</kwd>
<kwd>Neuroscience</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>Simons Foundation</funding-source>
<award-id>388449</award-id>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>Academia Sinica</funding-source>
<award-id>AS‐103‐TP‐B05</award-id>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>Ministry of Science and Technology, Taiwan (MOST)</funding-source>
<award-id>104‐2321‐B‐001‐050</award-id>
<award-id>105‐B‐001‐031</award-id>
<award-id>104‐2811‐B‐001‐048</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="13"></fig-count>
<table-count count="0"></table-count>
<page-count count="15"></page-count>
<word-count count="10879"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>embr201642586</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>January 2017</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.0.0 mode:remove_FC converted:04.01.2017</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<p content-type="self-citation">
<mixed-citation id="embr201642586-cit-1001" publication-type="journal">
<source/>EMBO Reports (<year>2017</year>) <volume>18</volume>: <fpage>169</fpage>–<lpage>183</lpage>
</mixed-citation>
</p>
</notes>
</front>
<body>
<sec id="embr201642586-sec-0001">
<title>Introduction</title>
<p>Acute inflammation at early developmental stages has been suggested to cause brain dysfunction by interfering with neuronal development <xref ref-type="ref" rid="embr201642586-bib-0001">1</xref>, <xref ref-type="ref" rid="embr201642586-bib-0002">2</xref>, <xref ref-type="ref" rid="embr201642586-bib-0003">3</xref>. Microbial infection, programmed cell death, tissue injury, and metabolic stress provide the sources for immune activation and trigger inflammatory responses <xref ref-type="ref" rid="embr201642586-bib-0004">4</xref>. Innate pattern recognition receptors (PRRs) are the first line of defense molecules to recognize pathogen‐associated molecular patterns (PAMPs) derived from foreign pathogens and that detect endogenous stress signals through interactions with danger‐associated molecular patterns (DAMPs) <xref ref-type="ref" rid="embr201642586-bib-0005">5</xref>. The major PRRs include Toll‐like receptors (TLRs), C‐type lectin receptors, retinoic acid‐inducible gene 1 (RIG‐I)‐like receptors, Nod‐like receptors (NLRs), and cytosolic DNA sensors <xref ref-type="ref" rid="embr201642586-bib-0006">6</xref>, <xref ref-type="ref" rid="embr201642586-bib-0007">7</xref>.</p>
<p>TLRs are the best‐characterized transmembrane PRRs that recognize various exogenous and endogenous molecular patterns <xref ref-type="ref" rid="embr201642586-bib-0008">8</xref>, <xref ref-type="ref" rid="embr201642586-bib-0009">9</xref>. TLR1, TLR2, TLR4, TLR5, TLR6, and TLR11 are expressed on cell surfaces and recognize microbial membrane components, whereas TLR3, TLR7, TLR8, and TLR9 are expressed in endosomes to detect both microbial and endogenous nucleic acids <xref ref-type="ref" rid="embr201642586-bib-0006">6</xref>, <xref ref-type="ref" rid="embr201642586-bib-0008">8</xref>. Among them, TLR3 is widely expressed in multiple cell types and specifically recognizes double‐strand RNA (dsRNA) derived from viruses and dead cells <xref ref-type="ref" rid="embr201642586-bib-0004">4</xref>, <xref ref-type="ref" rid="embr201642586-bib-0008">8</xref>, <xref ref-type="ref" rid="embr201642586-bib-0010">10</xref>, <xref ref-type="ref" rid="embr201642586-bib-0011">11</xref>, <xref ref-type="ref" rid="embr201642586-bib-0012">12</xref>. Unlike other TLRs that use MYD88 to transduce signaling, TLR3 only acts through TIR domain‐containing adapter‐inducing interferon‐β (TRIF) to trigger antiviral type I interferon and proinflammatory cytokine expression <xref ref-type="ref" rid="embr201642586-bib-0007">7</xref>, <xref ref-type="ref" rid="embr201642586-bib-0008">8</xref>.</p>
<p>TLR3 has been suggested to influence brain function in many aspects. The classical antiviral activity of TLR3 protects the brain from several neurotropic viral infections, for example, herpes simplex virus (HSV) and West Nile virus (WNV) <xref ref-type="ref" rid="embr201642586-bib-0013">13</xref>. In addition to its canonical role in antiviral infection, TLR3 activation negatively regulates neural progenitor cell proliferation and axonal growth of dorsal root ganglia neurons <xref ref-type="ref" rid="embr201642586-bib-0014">14</xref>, <xref ref-type="ref" rid="embr201642586-bib-0015">15</xref>, suggesting roles for TLR3 in neurodevelopment. Indeed, TLR3 activation by virus invasion or administration of poly(I:C)—a synthetic dsRNA—at the early developmental stage increases the possibility of developing a psychiatric disorder such as autism or schizophrenia <xref ref-type="ref" rid="embr201642586-bib-0001">1</xref>, <xref ref-type="ref" rid="embr201642586-bib-0003">3</xref>, <xref ref-type="ref" rid="embr201642586-bib-0016">16</xref>. Moreover, using a mouse genetic model, research has further indicated that, in the absence of an immune challenge, <italic>Tlr3</italic> deletion enhances hippocampal‐dependent learning and memory, impairs amygdala‐related behavior, and increases anxiety <xref ref-type="ref" rid="embr201642586-bib-0017">17</xref>. Therefore, TLR3 acts as a sensor to detect exogenous pathogens, as well as endogenous developmental or stress signals, to modulate neural development and function.</p>
<p>Peripheral immune responses induced by TLR3 activation have been suggested as being involved in the regulation of neuronal development and brain function <xref ref-type="ref" rid="embr201642586-bib-0018">18</xref>, <xref ref-type="ref" rid="embr201642586-bib-0019">19</xref>. However, accumulated studies indicate that TLR3 is expressed in neural progenitors, sensory neurons, and hippocampal and cortical neurons <xref ref-type="ref" rid="embr201642586-bib-0014">14</xref>, <xref ref-type="ref" rid="embr201642586-bib-0015">15</xref>, <xref ref-type="ref" rid="embr201642586-bib-0020">20</xref>, <xref ref-type="ref" rid="embr201642586-bib-0021">21</xref>, <xref ref-type="ref" rid="embr201642586-bib-0022">22</xref>, with the evidence suggesting that poly(I:C) can directly activate TLR3 in neurons to control neuronal development, though the molecular mechanism is still unclear. Here, we used various mouse genetic models, combined with <italic>in vivo</italic> and <italic>in vitro</italic> poly(I:C) stimulation, to investigate the function and signaling of TLR3 activation in neuronal morphogenesis. Our results show that TLR3 uses a MYD88‐dependent pathway to regulate expression of a series of psychiatric disorder‐related genes, including <italic>Disc1</italic>, and subsequently influences neuronal development.</p>
</sec>
<sec id="embr201642586-sec-0002">
<title>Results</title>
<sec id="embr201642586-sec-0003">
<title>TLR3 activation impairs neuronal morphogenesis</title>
<p>To study the regulation of neuronal morphology by TLR3, we used GFP‐transfected cortical and hippocampal mixed cultures. The GFP signals were used to outline neuronal morphology. Neurons were treated with poly(I:C) at 2 days <italic>in vitro</italic> (DIV) and 5 DIV for 24 h. Echoing a previous study <xref ref-type="ref" rid="embr201642586-bib-0015">15</xref>, poly(I:C) treatment impaired axonal growth at 3 DIV in our system (Fig <xref ref-type="fig" rid="embr201642586-fig-0001">1</xref>A). Moreover, we found that both dendritic length and tip number were reduced after poly(I:C) treatment (Fig <xref ref-type="fig" rid="embr201642586-fig-0001">1</xref>B). The <italic>in vitro</italic> effect of poly(I:C) on axonal growth and dendritic arborization was mediated by TLR3, because <italic>Tlr3</italic>
<sup>−/−</sup> neurons did not respond to poly(I:C) (Fig <xref ref-type="fig" rid="embr201642586-fig-0001">1</xref>C). We then investigated the effect of TLR3 activation on neuronal morphogenesis <italic>in vivo</italic>. <italic>Thy1</italic>‐<italic>Yfp</italic> transgenic mice received an intraperitoneal injection of saline or poly(I:C) at P4 and P5, and neuron morphology was monitored at P7. At P7, the <italic>Thy1</italic>‐<italic>Yfp</italic> transgene was only expressed in a few projection neurons in the retrosplenial granular cortex (RGC) and caudal hippocampal regions. Based on the YFP signals, we found that systemic administration of poly(I:C) impaired dendritic arborization of the RGC neurons, which was reflected in shorter total dendritic length, fewer branch tips, and a reduced intersection number in Sholl analysis (Fig <xref ref-type="fig" rid="embr201642586-fig-0001">1</xref>D). The <italic>in vivo</italic> effect of poly(I:C) on dendritic arborization also depended on TLR3, since poly(I:C) did not inhibit dendritic growth of <italic>Tlr3</italic>
<sup>−/−</sup> mice (Fig <xref ref-type="fig" rid="embr201642586-fig-0001">1</xref>E). These results suggest that TLR3 activation impairs neuronal morphology <italic>in vitro</italic>, as well as <italic>in vivo</italic>.</p>
<fig fig-type="Figure" id="embr201642586-fig-0001" orientation="portrait" position="float" xml:lang="en">
<label>Figure 1</label>
<caption>
<title>TLR3 activation negatively regulates neuronal morphogenesis <italic>in vivo</italic> and <italic>in vitro</italic>
</title>
<p>
<list id="embr201642586-list-0002" list-type="simple"><list-item><label>A, B</label><p>Poly(I:C) treatment inhibits axonal growth at 3 DIV (A) and dendritic growth at 6 DIV (B) in WT neurons. Neurons were transfected with GFP at 1 or 4 DIV. One day later, neurons were treated with poly(I:C) for 24 h before harvest.</p></list-item><list-item><label>C</label><p> Axon and dendrite morphology of <italic>Tlr3</italic>
<sup>−/−</sup> neurons after poly(I:C) treatment.</p></list-item><list-item><label>D, E</label><p>Neuronal morphology in saline‐ and poly(I:C)‐treated <italic>Tlr3</italic>
<sup>+/+</sup>
<italic>;Thy1‐Yfp</italic> (D) and <italic>Tlr3</italic>
<sup>−/−</sup>;<italic>Thy1‐Yfp</italic> (E) mouse brains. Total dendrite length, dendritic tip number, and Sholl analysis of dendritic processes were used to examine the dendrite phenotype.</p></list-item></list>Data information: (A–C) Data were analyzed by unpaired <italic>t</italic>‐test. Mean values ± SEM of representatives of three independent experiments are shown. The numbers of analyzed neurons in the representative experiments are indicated in each column. (D, E) Data of dendrite length and tip number were analyzed by unpaired <italic>t</italic>‐test. The Sholl data were analyzed by two‐way ANOVA with Bonferroni's multiple comparison test. The numbers of analyzed neurons and mice are presented in each column. Mean values ± SEM are shown. *<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.001, ***<italic>P</italic> &lt; 0.0001. Scale bar: 20 μm in (A) and (B), 50 μm in (D) and (E).</p>
</caption>
<graphic id="nlm-graphic-5" xlink:href="EMBR-18-169-g002"></graphic>
</fig>
</sec>
<sec id="embr201642586-sec-0004">
<title>MYD88 acts downstream of TLR3 in controlling dendritogenesis</title>
<p>To investigate the downstream pathway of TLR3 in controlling dendritic arborization, <italic>Trif</italic>‐mutant <xref ref-type="ref" rid="embr201642586-bib-0023">23</xref> and <italic>Myd88</italic>
<sup>−/−</sup>
<xref ref-type="ref" rid="embr201642586-bib-0024">24</xref> neurons were treated with poly(I:C). Unexpectedly, although <italic>Trif</italic> mutation impaired the cytokine production triggered by TLR3 activation (Fig <xref ref-type="fig" rid="embr201642586-fig-0001ev">EV1</xref>), <italic>Trif</italic>‐mutant neurons still had shorter dendrites and fewer dendritic tips in the presence of poly(I:C) (Fig <xref ref-type="fig" rid="embr201642586-fig-0002">2</xref>A). For <italic>Myd88</italic>
<sup>−/−</sup> mice, the production of peripheral inflammatory cytokines is greatly reduced in response to TLR activation <xref ref-type="ref" rid="embr201642586-bib-0024">24</xref>. <italic>Myd88</italic>
<sup>−/−</sup> neurons also lost the response to TLR7 activation <xref ref-type="ref" rid="embr201642586-bib-0020">20</xref>, indicating that Myd88 is indeed functionally ablated in knockout mice. Here, we found that, similar to TLR7 activation, <italic>Myd88</italic>
<sup>−/−</sup> neurons also did not respond to TLR3 activation via poly(I:C) treatment (Fig <xref ref-type="fig" rid="embr201642586-fig-0002">2</xref>B), suggesting that MYD88 is required for TLR3 to inhibit dendritic growth. To further confirm the roles of MYD88 and TRIF in dendritic growth, MYD88 and TRIF were overexpressed in cultured neurons. We found that only MYD88 overexpression was able to shorten the dendritic length (Fig <xref ref-type="fig" rid="embr201642586-fig-0002">2</xref>C), suggesting that MYD88 overexpression triggers the downstream signaling to shorten dendritic length.</p>
<fig fig-type="Figure" id="embr201642586-fig-0001ev" orientation="portrait" position="float" specific-use="collapsible" xml:lang="en">
<label>Figure EV1</label>
<caption>
<title>
<italic>Trif</italic>‐mutant neurons lose the response to poly(I:C) stimulation</title>
<p>At 5 DIV, <italic>Trif</italic>‐mutant neurons were treated with poly(I:C) for 6 h, RNAs were extracted, and the expression levels of <italic>Tnfa</italic>,<italic> Ifnb</italic>, and <italic>Il1b</italic> were examined by using quantitative RT‐PCR. The scales of <italic>y</italic>‐axes are identical to those in Fig <xref ref-type="fig" rid="embr201642586-fig-0004">4</xref>A for the responses of wild‐type neurons to poly(I:C) and saline control. For <italic>Ifnb</italic>, the expression levels in response to poly(I:C) decreased dramatically from 100‐fold to 4‐fold relative to <italic>Hprt</italic> transcripts when comparing wild‐type and <italic>Trif</italic>‐mutant neurons; although, compared with saline control, poly(I:C) still increased <italic>Ifnb</italic> expression in <italic>Trif</italic>‐mutant neurons. Data were analyzed by unpaired <italic>t</italic>‐test. <italic>N</italic> = 6. Mean values ± SEM are shown. **<italic>P</italic> &lt; 0.001.</p>
</caption>
<graphic id="nlm-graphic-7" xlink:href="EMBR-18-169-g003"></graphic>
</fig>
<fig fig-type="Figure" id="embr201642586-fig-0002" orientation="portrait" position="float" xml:lang="en">
<label>Figure 2</label>
<caption>
<title>TLR3 acts through MYD88 to regulate neuronal morphology</title>
<p>
<list id="embr201642586-list-0003" list-type="simple"><list-item><label>A, B</label><p>Quantitation of dendrite morphology of <italic>Trif</italic>‐mutant neurons (A) and <italic>Myd88</italic>
<sup>−/−</sup> neurons (B) after poly(I:C) stimulation. <italic>Trif</italic>‐mutant or <italic>Myd88</italic>
<sup>−/−</sup> neurons were transfected with a GFP construct at 4 DIV and treated with poly(I:C) 1 day later. Neuron morphology was analyzed at 6 DIV according to the GFP signal. Mean values ± SEM of representatives of three independent experiments are shown. The numbers of analyzed neurons in the representative experiments are indicated in each column. Data were analyzed by unpaired <italic>t</italic>‐test.</p></list-item><list-item><label>C</label><p>MYD88, but not TRIF, expression reduces dendrite outgrowth. HA‐tagged MYD88 and TRIF were cotransfected with a GFP construct into cultured wild‐type (WT) neurons at 4 DIV, and cell morphology was analyzed at 6 DIV. Mean values ± SEM of representatives of three independent experiments are shown. The numbers of analyzed neurons in the representative experiments are indicated in each column. Data were analyzed by one‐way ANOVA with Bonferroni's multiple comparison test.</p></list-item><list-item><label>D</label><p>MYD88 knockdown, but not TRIF knockdown, robustly increases dendritic arbors and loses the response to poly(I:C). Three DIV neurons were transfected with control shRNA (shCtrl), MYD88 shRNA (shMYD88), or TRIF shRNA (shTRIF) and poly(I:C) was applied into the culture at 5 DIV for 24 h before harvest. Mean values ± SEM of representatives of three independent experiments are shown. The numbers of analyzed neurons in the representative experiments are indicated in each column. Data were analyzed by two‐way ANOVA with Bonferroni's multiple comparison test.</p></list-item></list>Data information: Scale bars, 20 μm. ***<italic>P</italic> &lt; 0.0001. See also Figs <xref ref-type="fig" rid="embr201642586-fig-0001ev">EV1</xref> and <xref ref-type="fig" rid="embr201642586-fig-0002ev">EV2</xref>.</p>
</caption>
<graphic id="nlm-graphic-9" xlink:href="EMBR-18-169-g004"></graphic>
</fig>
<p>The effect of MYD88 on dendritic growth was also investigated by transfecting wild‐type neurons with the knockdown construct shMYD88. We found that MYD88 knockdown in cultured neurons was sufficient to promote dendritic growth (Fig <xref ref-type="fig" rid="embr201642586-fig-0002">2</xref>D), suggesting the presence of intrinsic stimulants in the culture that downregulate dendritic growth via MYD88. Addition of poly(I:C) did not shorten the dendritic length of MYD88‐knockdown neurons, echoing the results from <italic>Myd88</italic>
<sup>−/−</sup> neurons showing that the effect of poly(I:C) on dendritic growth is mediated by MYD88. In contrast to MYD88, TRIF knockdown did not influence dendritic growth (Fig <xref ref-type="fig" rid="embr201642586-fig-0002">2</xref>D) and poly(I:C) treatment still restricted dendritic growth of TRIF‐knockdown neurons (Fig <xref ref-type="fig" rid="embr201642586-fig-0002">2</xref>D). The knockdown effects of MYD88 shRNA and TRIF shRNA on MYD and TRIF expression are shown in Fig <xref ref-type="fig" rid="embr201642586-fig-0002ev">EV2</xref>. Together, these results suggest that TLR3 activation by poly(I:C) uses a MYD88‐dependent pathway to inhibit dendritic growth.</p>
<fig fig-type="Figure" id="embr201642586-fig-0002ev" orientation="portrait" position="float" specific-use="collapsible" xml:lang="en">
<label>Figure EV2</label>
<caption>
<title>The knockdown efficiency of MYD88‐ and TRIF‐knockdown constructs</title>
<p>
<list id="embr201642586-list-0009" list-type="simple"><list-item><label>A, B</label><p>Non‐silencing control shRNA (shCtrl), MYD88 shRNA (shMYD88), or TRIF shRNA (shTRIF) was cotransfected with HA‐tagged MYD88 or HA‐TRIF into HEK293T cells. Twenty‐four hours later, total cell extract was collected and subjected to immunoblot analysis. The effects of (A) shMYD88 and (B) shTRIF are shown. Immunoblotting was performed with HA tag and β‐actin antibodies. β‐Actin was used as a loading control. Molecular mass standards (kD) are indicated next to the gel blots.</p></list-item></list>
</p>
</caption>
<graphic id="nlm-graphic-11" xlink:href="EMBR-18-169-g005"></graphic>
</fig>
</sec>
<sec id="embr201642586-sec-0005">
<title>The N‐terminal region of MYD88 is critical for TLR3 signaling</title>
<p>TLRs typically deliver the signals to their downstream TIR domain‐containing adaptor via a direct protein–protein interaction of the TIR domains <xref ref-type="ref" rid="embr201642586-bib-0025">25</xref>. To further investigate the role of MYD88 in the TLR3 pathway, we examined the interaction between TLR3 and MYD88 using coimmunoprecipitation. In HEK293 cells, Myc‐tagged full‐length TLR3, but not the ectodomain of TLR3, was coprecipitated with HA tag antibody in the presence of HA‐tagged MYD88 (Fig <xref ref-type="fig" rid="embr201642586-fig-0003">3</xref>A), suggesting a specific interaction between the cytoplasmic domain of TLR3 and MYD88. In addition, this interaction was enhanced in the presence of poly(I:C), as there was more TLR3 associated with the MYD88 immunocomplex upon poly(I:C) stimulation (Fig <xref ref-type="fig" rid="embr201642586-fig-0003">3</xref>B). Although the TIR domain of MYD88 is the region that interacts with various TLRs <xref ref-type="ref" rid="embr201642586-bib-0026">26</xref>, we found that the C‐terminal TIR domain of MYD88 was not coprecipitated with TLR3 (Fig <xref ref-type="fig" rid="embr201642586-fig-0003">3</xref>C). Instead, the N‐terminal region of MYD88 that contains the death and intermediate domains precipitated with TLR3 (Fig <xref ref-type="fig" rid="embr201642586-fig-0003">3</xref>C). These results suggest that MYD88 uses a special mechanism to interact with TLR3.</p>
<fig fig-type="Figure" id="embr201642586-fig-0003" orientation="portrait" position="float" xml:lang="en">
<label>Figure 3</label>
<caption>
<title>TLR3 interacts with MYD88</title>
<p>
<list id="embr201642586-list-0004" list-type="alpha-upper"><list-item><p>Coimmunoprecipitation of TLR3 and MYD88. HEK293T cells were transfected with the indicated constructs. Twenty‐four hours later, immunoprecipitation (IP) was performed using HA antibody. The precipitates were immunoblotted (IB) with Myc and HA antibodies as indicated. EC, TLR3 ectodomain.</p></list-item><list-item><p>Poly(I:C) treatment increases the interaction between TLR3 and MYD88. One day after transfection, cells were treated with saline or poly(I:C) for 30 min before harvesting.</p></list-item><list-item><p>Upper, schematic of MYD88 constructs. DD, death domain; ID, intermediate domain; TIR, TIR domain. Lower, coimmunoprecipitation of TLR3 and the N‐terminal region of MYD88. For (A–C), representatives of three independent experiments are shown.</p></list-item><list-item><p>Full‐length and N‐terminal MYD88 inhibit dendrite outgrowth. <italic>Myd88</italic>
<sup>−/−</sup> neurons were transfected with control vector (Ctrl), HA‐tagged MYD88 (MYD88), N‐terminal MYD88 (MYD88‐N), or C‐terminal MYD88 (MYD88‐C) with a GFP construct. Poly(I:C) was applied into the culture at 5 DIV and neuronal morphology was analyzed at 6 DIV. Mean values ± SEM of representatives of three independent experiments are shown. The numbers of analyzed neurons in the representative experiments are indicated in each column. Data were analyzed by two‐way ANOVA with Bonferroni's multiple comparison test. ***<italic>P</italic> &lt; 0.0001. Scale bar, 20 μm.</p></list-item><list-item><p>Expression patterns of full‐length and truncated fragments of MYD88 in <italic>Myd88</italic>
<sup>−/−</sup> neurons. Representative images are shown. Scale bar, 20 μm.</p></list-item></list>
</p>
</caption>
<graphic id="nlm-graphic-13" xlink:href="EMBR-18-169-g006"></graphic>
</fig>
<p>To further investigate the role of the MYD88 N‐terminal region in neurons, we transfected MYD88‐N, MYD88‐C, and full‐length constructs into <italic>Myd88</italic>
<sup>−/−</sup> neurons and monitored their effects on dendritic growth. We found that, similar to wild‐type neurons (Fig <xref ref-type="fig" rid="embr201642586-fig-0002">2</xref>C), Myd88 overexpression in <italic>Myd88</italic>
<sup>−/−</sup> neurons reduced dendritic length (Fig <xref ref-type="fig" rid="embr201642586-fig-0003">3</xref>D). Poly(I:C) treatment did not further shorten dendritic length, supporting that poly(I:C) and MYD88 act on the same pathway to regulate dendritic growth. MYD88‐N exhibited a similar pattern as full‐length MYD88 in regulating dendritic growth (Fig <xref ref-type="fig" rid="embr201642586-fig-0003">3</xref>D), suggesting the essential and sufficient role of the N‐terminal region of MYD88 for dendritic regulation. In contrast to MYD88‐N and full‐length proteins, MYD88‐C did not have an effect on dendritic length, either in the presence or in the absence of poly(I:C) (Fig <xref ref-type="fig" rid="embr201642586-fig-0003">3</xref>D). These data strengthen our evidence for the function of the N‐terminal region of MYD88 in controlling dendritic growth.</p>
<p>When we analyzed the <italic>Myd88</italic> constructs in neurons, we noticed that full‐length MYD88 formed aggregates in neurons (Fig <xref ref-type="fig" rid="embr201642586-fig-0003">3</xref>E). For MYD88‐N, ~70–80% of transfected cells also contained MYD88‐N aggregates (Fig <xref ref-type="fig" rid="embr201642586-fig-0003">3</xref>E, MYD88‐N (1)). In the remaining 20–30% of transfected cells, MYD88‐N tended to concentrate at the edges of soma and entire dendritic processes (Fig <xref ref-type="fig" rid="embr201642586-fig-0003">3</xref>E, MYD88‐N (2)). MYD88‐C was always evenly distributed in neurons (Fig <xref ref-type="fig" rid="embr201642586-fig-0003">3</xref>E). Previous study has shown that MYD88 aggregation via its N‐terminal death domain is required for its activation and signal delivery to the downstream kinases <xref ref-type="ref" rid="embr201642586-bib-0027">27</xref>, <xref ref-type="ref" rid="embr201642586-bib-0028">28</xref>. Formation of protein aggregates suggests that overexpression of full‐length and the N‐terminal region of MYD88 in neurons is sufficient to activate the MYD88 downstream pathway, consistent with the aforementioned finding that overexpression of full‐length and the N‐terminal region of MYD88 restricted dendritic growth (Fig <xref ref-type="fig" rid="embr201642586-fig-0003">3</xref>D).</p>
</sec>
<sec id="embr201642586-sec-0006">
<title>Cytokines are not required for the effect of TLR3 on neurons</title>
<p>In general, TLR activation triggers expression of inflammatory and/or antiviral cytokines <xref ref-type="ref" rid="embr201642586-bib-0005">5</xref>. A previous study showed that addition of these cytokines to cultured neurons impairs dendritic growth <xref ref-type="ref" rid="embr201642586-bib-0029">29</xref>. We wondered whether cytokines are involved in the function of TLR3 in dendritic morphogenesis. Upon poly(I:C) stimulation, the RNA levels of <italic>Tnfa</italic>,<italic> Il‐1β</italic>, and <italic>Ifnb</italic> increased, but <italic>Il6</italic> was not upregulated (Fig <xref ref-type="fig" rid="embr201642586-fig-0004">4</xref>A). To investigate the roles of these cytokines, two sets of experiments were performed. The first one was to use poly(I:C) to stimulate <italic>Tnfa</italic>
<sup>−/−</sup> neurons. <italic>Il6</italic>
<sup>−/−</sup> neurons were also included as a negative control, since TLR3 activation did not induce <italic>Il6</italic> expression in cultured neurons. The results showed that poly(I:C) still effectively inhibited dendritic growth of these cytokine‐deficient neurons (Fig <xref ref-type="fig" rid="embr201642586-fig-0004">4</xref>B and C), suggesting that IL‐6, as well as TNF‐α, is not critical for TLR3‐regulated dendritic growth. However, it is still possible that TLR3 activation induces expression of other cytokine(s) rather than TNF‐α to control dendritic growth. Therefore, we performed a second experiment using conditioned medium, which investigated whether neurons secrete cytokines into the culture medium to inhibit dendritic growth. Using conditioned medium, our previous study demonstrated that neuronal TLR7 activation promotes IL‐6 secretion and then inhibits dendritic growth <xref ref-type="ref" rid="embr201642586-bib-0020">20</xref>. Here, the same experimental design was applied to explore whether TLR3 activation stimulates secretion of unknown factors into the medium to downregulate dendritic growth (Fig <xref ref-type="fig" rid="embr201642586-fig-0004">4</xref>D, left panel). The conditioned medium of poly(I:C)‐treated neurons was collected and applied to naïve recipient neurons (Fig <xref ref-type="fig" rid="embr201642586-fig-0004">4</xref>D, left panel). In WT recipient neurons, poly(I:C)‐treated conditioned medium inhibited dendritic growth, just like for the results of neurons treated directly with poly(I:C) (Fig <xref ref-type="fig" rid="embr201642586-fig-0004">4</xref>D, right upper panel). However, we were concerned that the residual poly(I:C) in the conditioned medium was still able to activate the TLR3 of recipient neurons and result in dendritic shortening. To examine this possibility, we added the conditioned medium to <italic>Tlr3</italic>
<sup>−/−</sup> neurons and found that the poly(I:C)‐treated conditioned medium was unable to inhibit dendritic growth of <italic>Tlr3</italic>
<sup>−/−</sup> neurons (Fig <xref ref-type="fig" rid="embr201642586-fig-0004">4</xref>D, right lower panel). These results suggest that TLR3 activation does not use secreted factor(s) to negatively control dendritic growth.</p>
<fig fig-type="Figure" id="embr201642586-fig-0004" orientation="portrait" position="float" xml:lang="en">
<label>Figure 4</label>
<caption>
<title>TLR3 activation does not use secreted factors to regulate neuronal morphology</title>
<p>
<list id="embr201642586-list-0005" list-type="simple"><list-item><label>A</label><p>Quantitative RT‐PCR analysis of proinflammatory cytokines <italic>Il6</italic>,<italic> Tnfa</italic>,<italic> Il1b</italic> and antiviral cytokine <italic>Ifnb</italic> in WT cultured cortical and hippocampal neurons. Data were analyzed by unpaired <italic>t</italic>‐test. <italic>Il6</italic> and <italic>Tnfa</italic>,<italic> N</italic> = 8; <italic>Ifnb</italic> and <italic>Il1b</italic>,<italic> N</italic> = 6.</p></list-item><list-item><label>B, C</label><p>Poly(I:C) treatment inhibits dendrite outgrowth of <italic>Il6</italic>
<sup>−/−</sup> neurons (B) and <italic>Tnfa</italic>
<sup>−/−</sup> neurons (C).</p></list-item><list-item><label>D</label><p>Left, schematic of experiment using conditioned medium. Upper right, conditioned medium applied to WT neurons. Lower right, conditioned medium applied to <italic>Tlr3</italic>
<sup>−/−</sup> neurons. Dendrite morphology was analyzed 1 day after adding conditioned medium.</p></list-item></list>Data information: Mean values ± SEM of representatives of three independent experiments are shown. The numbers of analyzed neurons in the representative experiments are indicated in each column. Data were analyzed by unpaired <italic>t</italic>‐test. *<italic>P</italic> &lt; 0.05, ***<italic>P</italic> &lt; 0.0001.</p>
</caption>
<graphic id="nlm-graphic-15" xlink:href="EMBR-18-169-g008"></graphic>
</fig>
</sec>
<sec id="embr201642586-sec-0007">
<title>TLR3 activation cell‐autonomously regulates dendritogenesis</title>
<p>The aforementioned results suggest that a secreted factor is not involved in the effect of TLR3 on dendritic morphology. It seems possible that TLR3 activation acts cell‐autonomously to control neuronal morphology. To address the possibility, we applied TLR3 shRNA (shTLR3) to reduce TLR3 expression (Fig <xref ref-type="fig" rid="embr201642586-fig-0003ev">EV3</xref>). Since the knockdown construct coexpresses GFP, we can use GFP signal to identify the transfected neurons and outline neuronal morphology. Given that transfection efficiency in our neuronal cultures is &lt; 1%, shTLR3‐transfected neurons are expected to be surrounded by many non‐transfected cells that still secrete cytokines in response to poly(I:C) stimulation. Therefore, TLR3‐knockdown neurons are still exposed to cytokines upon poly(I:C) treatment. For neurons transfected with non‐silencing control shCtrl <xref ref-type="ref" rid="embr201642586-bib-0030">30</xref>, poly(I:C) treatment obviously restricted dendritic growth (Fig <xref ref-type="fig" rid="embr201642586-fig-0005">5</xref>). For shTLR3‐expressing neurons, poly(I:C) treatment did not shorten dendritic length (Fig <xref ref-type="fig" rid="embr201642586-fig-0005">5</xref>), supporting that secreted factors do not cause dendritic growth deficits under poly(I:C) treatment and that TLR3 activation acts cell‐autonomously to downregulate dendritic growth. Note that, similar to MYD88 knockdown (Fig <xref ref-type="fig" rid="embr201642586-fig-0002">2</xref>D), TLR3 knockdown resulted in longer dendrites compared with control shCtrl (Fig <xref ref-type="fig" rid="embr201642586-fig-0005">5</xref>), which also indicates the presence of an intrinsic ligand for TLR3 in the cultures. Because both mRNAs and the microtubule‐binding protein, stathmin, have been shown to serve as intrinsic ligands of TLR3 <xref ref-type="ref" rid="embr201642586-bib-0012">12</xref>, <xref ref-type="ref" rid="embr201642586-bib-0031">31</xref>, dead cells in the cultures likely provide intrinsic stimulants to activate TLR3 and restrict dendritic growth. When TLR3 expression levels were reduced, knockdown neurons became unresponsive to the intrinsic ligands and grew better. Our previous study of TLR7 also indicated that neuronal TLR7 recognizes single‐stranded RNA in cultures and restricts dendritic growth <xref ref-type="ref" rid="embr201642586-bib-0020">20</xref>. Thus, both TLR7 and TLR3 are able to use a cell‐autonomous mechanism to regulate dendritic growth.</p>
<fig fig-type="Figure" id="embr201642586-fig-0003ev" orientation="portrait" position="float" specific-use="collapsible" xml:lang="en">
<label>Figure EV3</label>
<caption>
<title>The effect of the TLR3‐knockdown construct on TLR3 expression</title>
<p>Control shRNA (shCtrl) or TLR3 shRNA (shTLR3) was cotransfected with Myc‐tagged TLR3 into HEK293T cells. Total cell extract was collected 24 h later and subjected to immunoblot analysis. Immunoblotting was performed with Myc tag and α‐tubulin antibodies. α‐Tubulin was used as a loading control.</p>
</caption>
<graphic id="nlm-graphic-17" xlink:href="EMBR-18-169-g007"></graphic>
</fig>
<fig fig-type="Figure" id="embr201642586-fig-0005" orientation="portrait" position="float" xml:lang="en">
<label>Figure 5</label>
<caption>
<title>TLR3 knockdown in neurons promotes dendrite outgrowth and is resistant to poly(I:C) stimulation</title>
<p>At 4 DIV, cultured cortical neurons were transfected with indicated plasmids. Three days later, neurons were treated with 10 μg/ml poly(I:C) for 24 h. Neuronal morphology was monitored by GFP signals at 8 DIV. Mean values ± SEM of representatives of three independent experiments are shown. The numbers of analyzed neurons in the representative experiments are indicated in each column. Data were analyzed by two‐way ANOVA with Bonferroni's multiple comparison test. Scale bar, 20 μm. ***<italic>P</italic> &lt; 0.0001, ns: non‐significant. See also Fig <xref ref-type="fig" rid="embr201642586-fig-0003ev">EV3</xref>.</p>
</caption>
<graphic id="nlm-graphic-19" xlink:href="EMBR-18-169-g010"></graphic>
</fig>
</sec>
<sec id="embr201642586-sec-0008">
<title>TLR3 regulates expression of psychiatric disease genes</title>
<p>TLR3 activation at early developmental stages induces autism‐ and schizophrenia‐like behavior <xref ref-type="ref" rid="embr201642586-bib-0032">32</xref>. Our aforementioned results also suggest that TLR3 activation in neurons restricts dendritic growth. Therefore, we wondered whether TLR3 activation alters the expression of genes that regulate neuronal morphology and also are associated with schizophrenia and/or autism. Quantitative RT–PCR was used to determine the expression levels of several autism‐ or schizophrenia‐related genes in response to poly(I:C) stimulation, namely <italic>Auts2</italic>,<italic> Cdh8</italic>,<italic> Disc1</italic>,<italic> Fmr1</italic>,<italic> Mecp2</italic>,<italic> Nrg1</italic>,<italic> Nrxn1</italic>,<italic> Pten</italic>,<italic> Shank3</italic>,<italic> Tbr1</italic>,<italic> Tsc1</italic>, and <italic>Ube3a</italic> (<xref ref-type="supplementary-material" rid="embr201642586-sup-0002">Table EV1</xref>). We found that except for <italic>Cdh8</italic>,<italic> Mecp2</italic>, and <italic>Tsc1</italic>, all remaining nine genes in the list were downregulated in cultured cortical and hippocampal neurons upon poly(I:C) stimulation (Fig <xref ref-type="fig" rid="embr201642586-fig-0006">6</xref>A). To confirm that the reduced expression of these genes is mediated by TLR3, the effect of poly(I:C) was examined using <italic>Tlr3</italic>
<sup>−/−</sup> neurons. The expression of <italic>Nrg1</italic>,<italic> Nrxn1</italic>,<italic> Shank3</italic>, and <italic>Tbr1</italic> genes was still reduced in <italic>Tlr3</italic>
<sup>−/−</sup> neurons upon poly(I:C) treatment (Fig <xref ref-type="fig" rid="embr201642586-fig-0006">6</xref>B), suggesting that TLR3 is not required for the effect of poly(I:C) on reducing <italic>Nrg1</italic>,<italic> Nrxn1</italic>,<italic> Shank3</italic>, and <italic>Tbr1</italic> expression. It also indicates that only <italic>Auts2</italic>,<italic> Disc1</italic>,<italic> Fmr1</italic>,<italic> Pten</italic>, and <italic>Ube3a</italic> were specifically regulated by TLR3 activation (Fig <xref ref-type="fig" rid="embr201642586-fig-0006">6</xref>B). In <italic>Myd88</italic>
<sup>−/−</sup> neurons, poly(I:C) treatment did not noticeably influence expressions of <italic>Auts2</italic>,<italic> Disc1</italic>,<italic> Fmr1</italic>,<italic> Pten</italic>, and <italic>Ube3a</italic> (Fig <xref ref-type="fig" rid="embr201642586-fig-0006">6</xref>C), consistent with the role of MYD88 in the TLR3 pathway. The <italic>in vivo</italic> expression of these five genes was further investigated by injection of poly(I:C) into P5 mice. We found that <italic>Auts2</italic>,<italic> Disc1</italic>,<italic> Fmr1</italic>, and <italic>Ube3a</italic> still had lower RNA expression levels in poly(I:C)‐treated mouse brains (Fig <xref ref-type="fig" rid="embr201642586-fig-0006">6</xref>D), indicating the role of TLR3 in controlling the expression of these autism‐ and schizophrenia‐related genes in brains.</p>
<fig fig-type="Figure" id="embr201642586-fig-0006" orientation="portrait" position="float" xml:lang="en">
<label>Figure 6</label>
<caption>
<title>TLR3 activation downregulates expression of neuropsychiatric disorder‐related genes</title>
<p>
<list id="embr201642586-list-0006" list-type="simple"><list-item><label>A</label><p>Expression of 12 neuropsychiatric disorder‐related genes in saline‐ and poly(I:C)‐treated WT neurons.</p></list-item><list-item><label>B</label><p>Expression of nine neuropsychiatric disorder‐related genes in poly(I:C)‐treated <italic>Tlr3</italic>
<sup>−/−</sup> neurons. Relative expression levels compared with vehicle control are shown. Dashed line indicates the level of saline control.</p></list-item><list-item><label>C, D</label><p>Expression of <italic>Aust2</italic>,<italic> Disc1</italic>,<italic> Fmr1</italic>,<italic> Pten,</italic> and <italic>Ube3a</italic> in poly(I:C)‐treated <italic>Myd88</italic>
<sup>−/−</sup> neurons (C) and poly(I:C)‐treated P5 WT mouse brains (D). Similar to (B), relative levels compared with vehicle control are shown. Dashed lines indicate the level of saline control.</p></list-item><list-item><label>E</label><p>DIV 5 WT neurons were treated with poly(I:C) for 24 h. The total neuronal lysates were subjected to immunoblotting with the indicated antibodies. VCP and β‐actin were used as loading controls. The protein levels were normalized with β‐actin.</p></list-item></list>Data information: Mean values ± SEM are shown. Data were analyzed by unpaired <italic>t</italic>‐test. *<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.001, ***<italic>P</italic> &lt; 0.0001. Numbers of experimental repeats (<italic>N</italic>) are indicated. <italic>N</italic> = 6 in (A–C) and <italic>N</italic> = 5 in (D). See also Figs <xref ref-type="fig" rid="embr201642586-fig-0004ev">EV4</xref> and <xref ref-type="fig" rid="embr201642586-fig-0005ev">EV5</xref>.</p>
</caption>
<graphic id="nlm-graphic-21" xlink:href="EMBR-18-169-g012"></graphic>
</fig>
<p>We further examined the protein levels of the aforementioned genes 24 h after poly(I:C) treatment, that is, the time‐point for monitoring dendritic morphology. Only DISC1 protein levels were obviously lower upon poly(I:C) stimulation (Fig <xref ref-type="fig" rid="embr201642586-fig-0006">6</xref>E). Moreover, the reduction in DISC1 protein levels was also dependent on TLR3 and MYD88, because poly(I:C) did not influence the DISC1 levels in <italic>Tlr3</italic>
<sup>−/−</sup> and <italic>Myd88</italic>
<sup>−/−</sup> neurons (Fig <xref ref-type="fig" rid="embr201642586-fig-0004ev">EV4</xref>). In addition, the results of immunostaining indicated that, similar to poly(I:C) treatment, MYD88 overexpression in neurons reduced DISC1 protein levels (Fig <xref ref-type="fig" rid="embr201642586-fig-0005ev">EV5</xref>). Together, these results suggest that TLR3 activation reduces <italic>Disc1</italic> expression in neurons in a MYD88‐dependent manner.</p>
<fig fig-type="Figure" id="embr201642586-fig-0004ev" orientation="portrait" position="float" specific-use="collapsible" xml:lang="en">
<label>Figure EV4</label>
<caption>
<title>Poly(I:C) does not alter DISC1 protein levels in <italic>Tlr3</italic>
<sup>−/−</sup> neurons or <italic>Myd88</italic>
<sup>−/−</sup> neurons</title>
<p>
<list id="embr201642586-list-0010" list-type="simple"><list-item><label>A, B</label><p>At 5 DIV, <italic>Tlr3</italic>
<sup>−/−</sup> (A) and <italic>Myd88</italic>
<sup>−/−</sup> (B) neurons were treated with poly(I:C) for 24 h. The total neuronal lysates were subjected to immunoblotting with the indicated antibodies. VCP and β‐actin were used as loading controls.</p></list-item></list>
</p>
</caption>
<graphic id="nlm-graphic-23" xlink:href="EMBR-18-169-g009"></graphic>
</fig>
<fig fig-type="Figure" id="embr201642586-fig-0005ev" orientation="portrait" position="float" specific-use="collapsible" xml:lang="en">
<label>Figure EV5</label>
<caption>
<title>Poly(I:C) treatment and MYD88 overexpression reduce the DISC1 protein levels in neurons</title>
<p>Neurons were transfected with control vector (Ctrl) or HA‐MYD88 (MYD88) with a GFP construct at 4 DIV. One day later, neurons were treated with saline or 10 μg/ml poly(I:C) for 24 h. Neurons were fixed and immunostained with DISC1 antibody at 6 DIV. Counterstaining with DAPI was performed to label the nuclei. DISC1 signal within the soma region (white dashed line as indicated) was quantified using ImageJ. The data were reproduced in two independent experiments. Only one set of representative data is shown. The dots indicate the relative DISC1 intensities of individual cells. The bars indicate mean of each group. Data were analyzed by one‐way ANOVA followed by Bonferroni's multiple comparison test. Ctrl − pIC versus Ctrl + pIC, <italic>P</italic> &lt; 0.0001; Ctrl − pIC versus MYD88 − pIC, <italic>P</italic> &lt; 0.0001. Scale bar, 20 μm.</p>
</caption>
<graphic id="nlm-graphic-25" xlink:href="EMBR-18-169-g011"></graphic>
</fig>
</sec>
<sec id="embr201642586-sec-0009">
<title>DISC1 acts downstream of TLR3 in regulating dendritic growth</title>
<p>We then investigated the functional role of DISC1 in TLR3‐dependent neuronal morphogenesis by overexpression of DISC1 in poly(I:C)‐treated neurons. Neurons overexpressing DISC1 were resistant to poly(I:C) treatment, as the total dendrite lengths and total numbers of dendritic branch tips of poly(I:C)‐treated <italic>Disc1</italic>‐transfected neurons were comparable with those of neurons treated with vehicle controls with or without DISC1 overexpression (Fig <xref ref-type="fig" rid="embr201642586-fig-0007">7</xref>A). The mouse DISC1 L604F mutant, which corresponds to the human DISC1 L607F mutant that is a common missense variant in schizophrenia patients <xref ref-type="ref" rid="embr201642586-bib-0033">33</xref>, <xref ref-type="ref" rid="embr201642586-bib-0034">34</xref>, was unable to rescue the dendritic defects caused by TLR3 activation (Fig <xref ref-type="fig" rid="embr201642586-fig-0007">7</xref>A), further suggesting the specific effect of DISC1 on the TLR3 pathway. In addition to the <italic>in vitro</italic>‐cultured neurons, we also applied <italic>in utero</italic> electroporation to investigate the rescue effect of DISC1 overexpression in brains. Similar to the results of <italic>Thy1‐Yfp</italic> mice (Fig <xref ref-type="fig" rid="embr201642586-fig-0001">1</xref>D), poly(I:C) treatment reduced the complexity of dendritic arbors in the layer 2/3 cortical neurons labeled with GFP by <italic>in utero</italic> electroporation (Fig <xref ref-type="fig" rid="embr201642586-fig-0007">7</xref>B). With additional DISC1 expression, the neurons had comparable dendrite length, dendritic tip number, and dendritic complexity in the saline‐ and poly(I:C)‐treated mice (Fig <xref ref-type="fig" rid="embr201642586-fig-0007">7</xref>C). These results demonstrate that DISC1 is critical for the effect of TLR3 activation on downregulation of dendritic morphogenesis.</p>
<fig fig-type="Figure" id="embr201642586-fig-0007" orientation="portrait" position="float" xml:lang="en">
<label>Figure 7</label>
<caption>
<title>DISC1 overexpression rescues the effects of TLR3 activation on dendritic arborization <italic>in vitro</italic> and <italic>in vivo</italic>
</title>
<p>
<list id="embr201642586-list-0007" list-type="simple"><list-item><label>A</label><p>Overexpression of WT DISC1, but not the DISC1 L604F mutant, in cultured neurons suppresses dendrite withdrawal induced by TLR3 activation. Mean values ± SEM of representatives of three independent experiments are shown. The numbers of analyzed neurons in the representative experiments are indicated in each column. Data were analyzed by two‐way ANOVA with Bonferroni's multiple comparison test. Scale bars, 20 μm. **<italic>P</italic> &lt; 0.001, ***<italic>P</italic> &lt; 0.0001.</p></list-item><list-item><label>B, C</label><p>Overexpression of DISC1 in cortical neurons of mouse brain is resistant to poly(I:C)‐triggered reduction in dendritic arborization. Vector control (Ctrl) (B) or Myc‐DISC1 (C) was coexpressed with GFP in cortical layer 2/3 neurons in mouse brain. After poly(I:C) injection at P4 and P5, the neuronal morphology was analyzed at P7 by tracing the GFP signals. The data of dendrite length and tip number were analyzed by unpaired <italic>t</italic>‐test. The Sholl data were analyzed by two‐way ANOVA with Bonferroni's multiple comparison test. The numbers of analyzed neurons collected from 3 to 4 mice of each group are indicated. Mean values ± SEM are shown. Scale bar, 30 μm. *<italic>P</italic> &lt; 0.05, ***<italic>P</italic> &lt; 0.0001.</p></list-item></list>
</p>
</caption>
<graphic id="nlm-graphic-27" xlink:href="EMBR-18-169-g013"></graphic>
</fig>
<p>In conclusion, these results support that TLR3 activation regulates expression of <italic>Disc1</italic> to control dendritic arborization.</p>
</sec>
<sec id="embr201642586-sec-0010">
<title>TLR3 activation impairs dendritic spinogenesis</title>
<p>We further investigated whether TLR3 activation also regulates dendritic spine formation. In cortical and hippocampal mixed cultures, poly(I:C) treatment increased dendritic spine density, but narrowed the spine heads at 18 DIV (Fig <xref ref-type="fig" rid="embr201642586-fig-0008">8</xref>A), suggesting that TLR3 activation alters dendritic spine formation. To further confirm this effect <italic>in vivo</italic>, we intraperitoneally injected poly(I:C) or saline vehicle control into <italic>Thy1‐Yfp</italic> mice at P4 and P5 and characterized dendritic spines of layer 5 pyramidal neurons of the somatosensory cortex at P21 (Fig <xref ref-type="fig" rid="embr201642586-fig-0008">8</xref>B). After being stimulated with poly(I:C), dendritic spine density was increased, whereas spine heads tended to be smaller (Fig <xref ref-type="fig" rid="embr201642586-fig-0008">8</xref>C), which is similar to what we observed in cultured neurons (Fig <xref ref-type="fig" rid="embr201642586-fig-0008">8</xref>A). The effect of poly(I:C) on dendritic spine density and size was TLR3‐specific, because dendritic spines of <italic>Tlr3</italic>
<sup>−/−</sup> mice were not altered by poly(I:C) treatment (Fig <xref ref-type="fig" rid="embr201642586-fig-0008">8</xref>D). In conclusion, these analyses suggest that TLR3 activation during the neonatal stage has a long‐lasting effect on dendritic spine formation at later stages.</p>
<fig fig-type="Figure" id="embr201642586-fig-0008" orientation="portrait" position="float" xml:lang="en">
<label>Figure 8</label>
<caption>
<title>TLR3 activation alters spine morphology <italic>in vitro</italic> and <italic>in vivo</italic>
</title>
<p>
<list id="embr201642586-list-0008" list-type="simple"><list-item><label>A</label><p>Cortical and hippocampal mixed neuronal cultures were transfected with a GFP construct at 12 DIV and treated with poly(I:C) (pIC) at 17 DIV for 24 h. Spine morphology was examined at 18 DIV. Three secondary dendrites of each neuron were selected to analyze the spine density, the width of the spine head, and the spine length. Mean values ± SEM of representatives of three independent experiments are shown. For the saline group, 15 neurons/45 dendrites were examined; for the poly(I:C) group, 16 neurons/48 dendrites were examined. Data were analyzed by unpaired <italic>t</italic>‐test. Scale bar, 20 μm in right upper panel and 5 μm in lower left panel. ***<italic>P</italic> &lt; 0.0001.</p></list-item><list-item><label>B</label><p>Schematic of the experimental procedure for <italic>in vivo</italic> spine morphology analysis in (C and D). Representative images of somatosensory cortical layer 5 neurons and a high magnification image of a secondary dendrite are shown. Scale bar, 100 μm in the brain section (black) and 10 μm in the dendrite segment (white).</p></list-item><list-item><label>C, D</label><p>Spine morphology of P21 <italic>Thy1‐Yfp</italic> (C) and <italic>Tlr3</italic>
<sup>−/−</sup>; <italic>Thy1‐Yfp</italic> mice (D) after poly(I:C) stimulation at P4 and P5. One secondary dendrite of an apical dendrite of each somatosensory layer 5 cortical neuron was selected to examine the spine morphology. Three mice were analyzed for each group. Saline‐treated <italic>Thy1‐Yfp</italic>, 44 neurons; poly(I:C)‐treated <italic>Thy1‐Yfp</italic>, 43 neurons; saline‐treated <italic>Tlr3</italic>
<sup>−/−</sup>
<italic>;Thy1‐Yfp</italic>, 46 neurons; poly(I:C)‐treated <italic>Tlr3</italic>
<sup>−/−</sup>
<italic>;Thy1‐Yfp</italic>, 50 neurons. Mean values ± SEM are shown. Data were analyzed by unpaired <italic>t</italic>‐test. Scale bars, 5 μm. ***<italic>P</italic> &lt; 0.0001.</p></list-item></list>
</p>
</caption>
<graphic id="nlm-graphic-29" xlink:href="EMBR-18-169-g014"></graphic>
</fig>
</sec>
</sec>
<sec id="embr201642586-sec-0011">
<title>Discussion</title>
<p>TLR3 is an endosomal TLR that recognizes viral and self dsRNA to trigger antiviral and inflammatory responses <xref ref-type="ref" rid="embr201642586-bib-0035">35</xref>. In this report, we found three unexpected properties of TLR3 signaling. First, MYD88, but not TRIF, is required for TLR3 to control dendritic growth. Second, MYD88 uses its N‐terminal death and intermediate domains, but not the TIR domain, to interact with the TLR3 cytoplasmic region. Third, although TLR3 activation in neurons induces cytokine expression, cytokines are not required for TLR3 to negatively regulate dendritic growth.</p>
<p>TLR3 is known to utilize only TRIF to elicit an antiviral response <xref ref-type="ref" rid="embr201642586-bib-0023">23</xref>, <xref ref-type="ref" rid="embr201642586-bib-0036">36</xref>, and involvement of other adaptor molecules has not been suggested for TLR3‐dependent signaling. Here, in our cultured neurons, the data suggest that TRIF is required for poly(I:C) treatment to induce cytokine expression. However, TRIF‐mediated cytokine production is not required for regulation of dendritic growth. Instead, TLR3 uses MYD88 to control neuronal morphology, indicating that TLR3 uses both TRIF and MYD88 to deliver its downstream signaling. The TRIF‐dependent signaling is needed to regulate cytokine expression. The MYD88‐dependent pathway is crucial to controlling neuronal morphology. It is well known that TLR4 uses both MYD88 and TRIF to induce inflammatory responses <xref ref-type="ref" rid="embr201642586-bib-0035">35</xref>. Recent studies have reported that TLR5 can also use TRIF to deliver signaling in intestinal epithelial cells <xref ref-type="ref" rid="embr201642586-bib-0037">37</xref>, and TLR9 acts through TRIF as well as Sarm1 to promote a tolerogenic response in plasmacytoid dendritic cells and induce apoptosis in neurons, respectively <xref ref-type="ref" rid="embr201642586-bib-0038">38</xref>, <xref ref-type="ref" rid="embr201642586-bib-0039">39</xref>. Therefore, canonical TLR signal pathways may not be applied universally. Distinct cell types and various physiological conditions may alter TLR signal pathways.</p>
<p>The death and TIR domains of MYD88 have been identified to interact with multiple proteins. Fas‐associated protein with death domain (FADD), interleukin‐1 receptor‐associated kinases (IRAKs), and interferon regulatory factor 7 (IRF7) bind to the death domain of MYD88 <xref ref-type="ref" rid="embr201642586-bib-0040">40</xref>, <xref ref-type="ref" rid="embr201642586-bib-0041">41</xref>, <xref ref-type="ref" rid="embr201642586-bib-0042">42</xref>, <xref ref-type="ref" rid="embr201642586-bib-0043">43</xref>. The TIR domain of MYD88 associates with IL‐1R, MYD88‐adapter‐like (MAL, #32), IRF3, and TLRs (except TLR3) <xref ref-type="ref" rid="embr201642586-bib-0026">26</xref>, <xref ref-type="ref" rid="embr201642586-bib-0044">44</xref>, <xref ref-type="ref" rid="embr201642586-bib-0045">45</xref>. Unlike other TLR–MYD88 interactions, the TLR3 and MYD88 interaction is a TIR domain to death domain association. This kind of TLR3–MYD88 interaction may form a different protein complex to trigger distinct cell responses. The downstream signaling of this TLR3–MYD88 complex needs to be further characterized.</p>
<p>Previous reports indicate that maternal cytokines, such as IL‐6 and IL‐17a, from pregnant mice infected with virus or receiving poly(I:C) stimulation cause abnormal fetal brain development and develop autism‐ and schizophrenic‐like behavior in adult offspring <xref ref-type="ref" rid="embr201642586-bib-0018">18</xref>, <xref ref-type="ref" rid="embr201642586-bib-0019">19</xref>, <xref ref-type="ref" rid="embr201642586-bib-0032">32</xref>. Some viruses are neurotropic and may cross the placenta to infect the fetus, for example, West Nile virus and Zika virus <xref ref-type="ref" rid="embr201642586-bib-0046">46</xref>, <xref ref-type="ref" rid="embr201642586-bib-0047">47</xref>, and these viruses have been suggested to trigger TLR3 signaling <xref ref-type="ref" rid="embr201642586-bib-0048">48</xref>, <xref ref-type="ref" rid="embr201642586-bib-0049">49</xref>. Therefore, both developing neurons and microglia may encounter the invasive virus directly and activate their TLR3 pathway to defend themselves from the foreign pathogens. Indeed, our data suggest that poly(I:C) treatment induces <italic>Tnfa</italic>,<italic> Il1b,</italic> and <italic>Ifnb</italic> expression in cultured neurons, which may be involved in defense against pathogenic infection. However, cytokines produced by neurons upon poly(I:C) stimulation are either inefficient or insufficient to modulate neuronal morphology. Instead, our data suggest that neuronal TLR3 controls expression of a series of autism‐ and schizophrenia‐related genes to regulate neuronal morphology. It is reasonable to speculate that in addition to peripheral and microglial immune responses <xref ref-type="ref" rid="embr201642586-bib-0021">21</xref>, <xref ref-type="ref" rid="embr201642586-bib-0032">32</xref>, <xref ref-type="ref" rid="embr201642586-bib-0050">50</xref>, neuronal TLR3 activation may also contribute to altering neuronal and brain function. It will be important to further verify the effect of neuronal TLR3 on brain development and function using neuron‐specific <italic>Tlr3</italic>‐knockout mice.</p>
<p>In this report, we provide evidence that the protein levels of DISC1 were noticeably reduced after poly(I:C) treatment. Overexpression of wild‐type DISC1, but not a mutant identified from schizophrenia patients, effectively rescues the dendritic defects caused by TLR3 activation, suggesting a critical role of DISC1 in TLR3‐regulated neurodevelopment. <italic>DISC1</italic> is associated with schizophrenia, autism, bipolar disorders, and depression <xref ref-type="ref" rid="embr201642586-bib-0051">51</xref>, <xref ref-type="ref" rid="embr201642586-bib-0052">52</xref>, <xref ref-type="ref" rid="embr201642586-bib-0053">53</xref>, <xref ref-type="ref" rid="embr201642586-bib-0054">54</xref>. It is a versatile molecule involved in neurogenesis, postmitotic neural migration, dendritic arborization, dendritic spine formation, and synaptic plasticity <xref ref-type="ref" rid="embr201642586-bib-0055">55</xref>, <xref ref-type="ref" rid="embr201642586-bib-0056">56</xref>, <xref ref-type="ref" rid="embr201642586-bib-0057">57</xref>, <xref ref-type="ref" rid="embr201642586-bib-0058">58</xref>, <xref ref-type="ref" rid="embr201642586-bib-0059">59</xref>. DISC1 associates with microtubule‐associated proteins, motor molecules, signaling proteins, and RNA binding proteins to influence cytoskeleton function, protein and RNA trafficking, and neuronal development and plasticity <xref ref-type="ref" rid="embr201642586-bib-0059">59</xref>, <xref ref-type="ref" rid="embr201642586-bib-0060">60</xref>, <xref ref-type="ref" rid="embr201642586-bib-0061">61</xref>, <xref ref-type="ref" rid="embr201642586-bib-0062">62</xref>, <xref ref-type="ref" rid="embr201642586-bib-0063">63</xref>, <xref ref-type="ref" rid="embr201642586-bib-0064">64</xref>. Reduction in DISC1 expression by TLR3 activation may then influence the downstream pathways of DISC1 and result in neurodevelopmental impairment. It would certainly be interesting to further determine whether a specific downstream effector of DISC1 is particularly sensitive to TLR3 activation.</p>
<p>Several studies have suggested that environment–genetic interactions play an important role in neurodevelopmental disorders. For instance, maternal immune activation and <italic>Tsc2</italic> haploinsufficiency work together to disturb social behavior in offspring <xref ref-type="ref" rid="embr201642586-bib-0065">65</xref>. Expression of the <italic>Disc1</italic> mutant in mice exacerbates the behavioral defects induced by poly(I:C) injections at prenatal stages <xref ref-type="ref" rid="embr201642586-bib-0066">66</xref>, <xref ref-type="ref" rid="embr201642586-bib-0067">67</xref>, <xref ref-type="ref" rid="embr201642586-bib-0068">68</xref>. Our study indicates regulation of DISC1 expression by TLR3 activation, implying that environmental factors, such as viral infection, regulate expression of the genes associated with psychiatric disorders and influence neurodevelopment. Our findings further support that genetic polymorphism plus environmental stimulations may contribute to the diversity of psychiatric disorders.</p>
<p>Our research shows that, compared with the saline control group, poly(I:C)‐treated mice had a higher dendritic spine density at P21, which resembles one of the common features of autism spectrum disorders, namely impaired synapse elimination during maturation <xref ref-type="ref" rid="embr201642586-bib-0069">69</xref>, <xref ref-type="ref" rid="embr201642586-bib-0070">70</xref>. Since TLR3 activation at P4 and P5 influences dendritic spine density and morphology at P21, this result indicates a long‐term effect of TLR3 activation on neurodevelopment. Recently, epigenetic reprogramming has been shown to control long‐lasting effects of innate immune responses in peripheral tissues <xref ref-type="ref" rid="embr201642586-bib-0071">71</xref>. It is very likely that neuronal innate immunity uses a similar mechanism to control gene expression over a long‐lasting period and thus impact on neural plasticity and cognition, which presents a very intriguing subject for future study.</p>
<p>In the current study, the RNA levels of <italic>Auts2</italic>,<italic> Disc1</italic>,<italic> Fmr1</italic>, and <italic>Ube3a</italic> were noticeably reduced upon TLR3 activation. However, only DISC1 proteins were obviously decreased 24 h after TLR3 activation. It is unclear why only DISC1 protein levels were altered. Perhaps, the other proteins are more stable and thus take a longer time to reflect the effect of RNA reduction. If TLR3 does alter the protein levels of these genes, these proteins may impact on other neuronal phenotypes or responses. It would be intriguing to examine these possibilities in the future.</p>
<p>A previous study showed that poly(I:C) treatment did not influence <italic>Disc1</italic> expression in mice <xref ref-type="ref" rid="embr201642586-bib-0072">72</xref>, which conflicts with the findings of our study. There are at least two possibilities to explain the discrepancy. First, an outbred strain of ICR mice was used in the previous paper, whereas we used mice in the C57BL/6 background in our study. Different genetic backgrounds may result in different responses to poly(I:C) stimulation. In particular, ICR mice, but not C57BL/6, have been shown to carry a 25‐bp deletion in the <italic>Disc1</italic> gene and cannot express full‐length DISC1 proteins <xref ref-type="ref" rid="embr201642586-bib-0073">73</xref>. Second, the experimental procedures between the previous work and our study differ. In our study, a single shot of poly(I:C) was intraperitoneally injected into neonatal mice at P5. Six hours later, cortex and hippocampus were harvested for quantitative RT‐PCR. In the previous work, poly(I:C) was injected once per day from P2 to P6. Only the hippocampus was harvested for quantitative RT‐PCR 2 and 24 h after the last injection. These differences may also contribute to the differences between our results and those of the previous study.</p>
<p>In conclusion, our data suggest that TLR3 uses a non‐canonical MYD88‐dependent pathway to control <italic>Disc1</italic> expression and cell‐autonomously regulate neuronal morphology. Neuronal innate immunity may regulate neuronal morphology in response to exogenous immune challenge as well as intrinsic developmental signals or stress responses.</p>
</sec>
<sec id="embr201642586-sec-0012">
<title>Materials and Methods</title>
<sec id="embr201642586-sec-0013">
<title>Animals and treatments</title>
<p>
<italic>Thy1‐Yfp</italic>
<xref ref-type="ref" rid="embr201642586-bib-0074">74</xref>, <italic>Tlr3</italic>
<sup>−/−</sup>
<xref ref-type="ref" rid="embr201642586-bib-0075">75</xref>, <italic>Trif</italic>‐mutant <xref ref-type="ref" rid="embr201642586-bib-0023">23</xref>, <italic>Myd88</italic>
<sup>−/−</sup>
<xref ref-type="ref" rid="embr201642586-bib-0024">24</xref>, <italic>Il6</italic>
<sup>−/−</sup>
<xref ref-type="ref" rid="embr201642586-bib-0076">76</xref>, and <italic>Tnfa</italic>
<sup>−/−</sup>
<xref ref-type="ref" rid="embr201642586-bib-0077">77</xref> mice in a C57BL/6 background were purchased from Jackson Laboratory. Animals were housed in the animal facility of the Institute of Molecular Biology, Academia Sinica, with a 12‐h light/12‐h dark cycle and controlled temperature and humidity. All animal experiments were performed with the approval of the Academia Sinica Institutional Animal Care and Utilization Committee and in strict accordance with its guidelines and those of the Council of Agriculture Guidebook for the Care and Use of Laboratory Animals. For cortical and hippocampal mixed neuronal cultures, E16‐17 mouse embryos of both genders were used. For <italic>in vivo</italic> neuronal morphology analysis, <italic>Thy1‐Yfp</italic> and <italic>Tlr3</italic>
<sup>−/−</sup>
<italic>;Thy1‐Yfp</italic> mice of both genders received an intraperitoneal injection of saline or 5 mg/kg poly(I:C) (HMW; InvivoGen) daily at P4 and P5. The brains were harvested at P7 for dendritic arbor analysis and at P21 for examining spine morphology. Neuronal morphology was monitored with YFP signal.</p>
</sec>
<sec id="embr201642586-sec-0014">
<title>Cell culture, transfection, drug treatment, immunoprecipitation, and immunoblotting</title>
<p>Transfections of HEK293T cells were performed using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions <xref ref-type="ref" rid="embr201642586-bib-0030">30</xref>. Mouse cortical and hippocampal mixed neurons were cultured in Neurobasal medium/DMEM (1:1) with B27 supplement and transfected using calcium phosphate precipitation methods as described <xref ref-type="ref" rid="embr201642586-bib-0020">20</xref>, <xref ref-type="ref" rid="embr201642586-bib-0030">30</xref>. Cotransfected or coexpressed GFP was used to outline neuronal morphology. Neurons were treated with 10 μg/ml poly(I:C) for 24 h before being harvested. Immunoprecipitation and immunoblotting were performed as described <xref ref-type="ref" rid="embr201642586-bib-0030">30</xref>, except that the protein signals were visualized and quantified using ImageQuant LAS 4000 with the software ImageQuant LAS 4000 Biomolecular Imager (GE Healthcare).</p>
</sec>
<sec id="embr201642586-sec-0015">
<title>Immunocytochemistry and immunohistochemistry</title>
<p>Immunostaining of cultured neurons and 100<italic>‐</italic>μm<italic>‐</italic>thick brain sections was performed as described <xref ref-type="ref" rid="embr201642586-bib-0030">30</xref>. Immunofluorescent images of cultured neurons were visualized at room temperature with a fluorescence microscope (Axioimage M2; Zeiss) equipped with a 20×/NA 0.80 (Plan‐Apochromat) objective lens and acquired using a cooled charge‐coupled device camera (Rolera EM‐C<sup>2</sup>; QImaging) with Zen software (Zeiss). For brain sections, neuronal images were captured at room temperature with a confocal microscope (LSM 700, Zeiss) equipped with a 20×/NA 0.80 (Plan‐Apochromat) objective lens and Zen acquisition and analysis software (Zeiss). The images were processed using Photoshop (Adobe) with minimal adjustment of brightness or contrast applied to the entire images. The camera lucida drawings were performed with ImageJ.</p>
</sec>
<sec id="embr201642586-sec-0016">
<title>
<italic>In utero</italic> electroporation</title>
<p>
<italic>In utero</italic> electroporation was performed as previously described with slight modifications <xref ref-type="ref" rid="embr201642586-bib-0022">22</xref>. Briefly, pregnant wild‐type B6 mice were exposed to 1.8% isoflurane in oxygen during surgery and the embryos at embryonic day 15 were used for <italic>in vivo</italic> electroporation of the cortex. Control plasmid pCAGEN (Addgene) or pCAG‐Myc‐DISC1 was mixed with pCAG‐GFP (Addgene) in a 3:1 ratio and injected into one of the lateral ventricles of embryo brain using a glass micropipette. The embryonic brain then received five pulses (30 V for 50 ms) of electric shock with 950‐ms intervals using an ECM830 square wave pulse generator (BTX, Harvard Apparatus). Poly(I:C) injection, perfusion, brain fixation/sectioning, and neuronal image acquisition were performed as described in the previous sections.</p>
</sec>
<sec id="embr201642586-sec-0017">
<title>Neuronal morphometry</title>
<p>For axons, the lengths of both the primary axon (i.e. the longest axon) and total axons were measured. For dendrites, the total dendrite length was measured, including primary dendrites and all dendritic branches, and the number of dendritic tips was counted. For neuronal morphology in brains, assessment of the intersection number in Sholl analysis <xref ref-type="ref" rid="embr201642586-bib-0078">78</xref> was also undertaken. For <italic>in vivo</italic> spine analysis, secondary dendrites of apical dendrites of layer 5 cortical neurons from the somatosensory cortex were chosen to examine spine density, the width of the spine head, and spine length. To minimize the effects of bias, the critical experiments were performed blind by relabeling the samples with the assistance of other laboratory members. For cultured neurons, all experiments were repeated at least three times. For each repeat, at least 30 neurons were randomly picked from each group for analysis. The conclusions of all results shown in this manuscript can be repeated in three independent experiments. For <italic>in vivo</italic> analysis, at least 30 neurons collected from three or more mice were used for analysis. All measurements were carried out using the software ImageJ.</p>
</sec>
<sec id="embr201642586-sec-0018">
<title>Quantitative RT‐PCR</title>
<p>Wild‐type (WT), <italic>Tlr3</italic>
<sup>−/−</sup>
<italic>,</italic> and <italic>Myd88</italic>
<sup>−/−</sup> cultured neurons were treated with 10 μg/ml poly(I:C) for 6 h before harvesting. To quantify gene expression in brains, WT mice received an intraperitoneal injection of saline or 5 mg/kg poly(I:C) at P5. Six hours after injection, mouse cortex and hippocampus were harvested for total RNA extraction using Trizol reagent according to the manufacturer's instructions (Invitrogen) followed by DNase I digestion (New England BioLabs). Reverse transcription and quantitative RT‐PCR analysis was performed using the Transcriptor First Strand cDNA Synthesis Kit (Roche) with an oligo(dT)18 primer and the Universal ProbeLibrary probes (UPL; Roche) system, respectively <xref ref-type="ref" rid="embr201642586-bib-0020">20</xref>, <xref ref-type="ref" rid="embr201642586-bib-0022">22</xref>. Primer sets for cytokines were as described <xref ref-type="ref" rid="embr201642586-bib-0020">20</xref>. The primer sets for neurodevelopmental disease genes and internal control <italic>Hprt</italic> for quantitative RT‐PCR analysis are listed in <xref ref-type="supplementary-material" rid="embr201642586-sup-0002">Table EV1</xref>. Levels of target mRNA were normalized to levels of <italic>Hprt</italic> mRNA measured at the same time on the same reaction plate.</p>
</sec>
<sec id="embr201642586-sec-0019">
<title>Antibodies and plasmids</title>
<p>Detailed information on the antibodies and DNA constructs used in this report is summarized in <xref ref-type="supplementary-material" rid="embr201642586-sup-0003">Tables EV2</xref> and <xref ref-type="supplementary-material" rid="embr201642586-sup-0004">EV3</xref>, respectively.</p>
</sec>
<sec id="embr201642586-sec-0020">
<title>Statistical analysis</title>
<p>Statistical analyses were performed using GraphPad Prism software. For animal studies, all available mice were subjected to analysis and no randomization was performed. No statistical methods were used to predetermine sample sizes, but our sample sizes are similar to those reported in previous publications <xref ref-type="ref" rid="embr201642586-bib-0020">20</xref>, <xref ref-type="ref" rid="embr201642586-bib-0030">30</xref>, <xref ref-type="ref" rid="embr201642586-bib-0079">79</xref>, <xref ref-type="ref" rid="embr201642586-bib-0080">80</xref>. No sample was excluded from the analyses. The majority of data met the assumption (normal distribution) of statistical tests, except Fig <xref ref-type="fig" rid="embr201642586-fig-0002">2</xref>A Tip/pIC, 4A Tnfa/Sal and Ifnb/Sal, 4B Tip/Sal, 4C Tip/pIC, 7C Tip/pIC, 8A width and length, 8C width and length, and 8D width and length. Experiments were performed blind by relabeling the samples with the assistance of other laboratory members. For two‐group experiments, the unpaired <italic>t</italic>‐test was used. For experiments with more than two groups, one‐way ANOVA with <italic>post hoc</italic> Bonferroni correction was applied. For the Sholl analysis, two‐way ANOVA with <italic>post hoc</italic> Bonferroni correction was used. Data are presented as the mean ± SEM.</p>
</sec>
</sec>
<sec id="embr201642586-sec-0022">
<title>Author contributions</title>
<p>C‐YC and Y‐PH were involved in conceptualization; C‐YC and H‐YL made investigation (H‐YL, initial analysis of Fig <xref ref-type="fig" rid="embr201642586-fig-0004">4</xref>A); C‐YC, H‐YL and Y‐PH were involved in writing; C‐YC and Y‐PH performed visualization; Y‐PH was involved in supervision, project administration and funding acquisition.</p>
</sec>
<sec id="embr201642586-sec-0023">
<title>Conflict of interest</title>
<p>The authors declare that they have no conflict of interest.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Supporting information</title>
<supplementary-material content-type="local-data"></supplementary-material>
<supplementary-material content-type="local-data" id="embr201642586-sup-0001">
<caption>
<p>Expanded View Figures PDF</p>
</caption>
<media xlink:href="EMBR-18-169-s001.pdf">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="embr201642586-sup-0002">
<caption>
<p>Table EV1</p>
</caption>
<media xlink:href="EMBR-18-169-s002.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="embr201642586-sup-0003">
<caption>
<p>Table EV2</p>
</caption>
<media xlink:href="EMBR-18-169-s003.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="embr201642586-sup-0004">
<caption>
<p>Table EV3</p>
</caption>
<media xlink:href="EMBR-18-169-s004.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data">
<caption>
<p>Review Process File</p>
</caption>
<media xlink:href="EMBR-18-169-s005.pdf">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
</body>
<back>
<ack id="embr201642586-sec-0021">
<title>Acknowledgements</title>
<p>We thank Dr. Kozo Kaibuchi (Nagoya University, Japan) for the kind gifts of the <italic>Disc1</italic> construct and antibody; Dr. Constance L. Cepko for the pCAGEN (Addgene plasmid # 11160) and pCAG‐GFP (Addgene plasmid # 11150); the Genomic Core Facility of the Institute of Molecular Biology, Academia Sinica, for technical support; Dr. John O'Brien for English editing; and the members of Yi‐Ping Hsueh's laboratory for relabeling samples for the blinded experiments. This work was supported by grants from the Simons Foundation (SFARI# 388449), Academia Sinica (AS‐103‐TP‐B05), and the Ministry of Science and Technology (MOST 104‐2321‐B‐001‐050 and 105‐B‐001‐031) to Y.‐P. Hsueh. C.‐Y. Chen is also supported by the Ministry of Science and Technology (MOST 104‐2811‐B‐001‐048).</p>
</ack>
<ref-list content-type="cited-references" id="embr201642586-bibl-0001">
<title>References</title>
<ref id="embr201642586-bib-0001">
<label>1</label>
<mixed-citation id="embr201642586-cit-0001" publication-type="journal">
<string-name>
<surname>Knuesel</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Chicha</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Britschgi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Schobel</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Bodmer</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hellings</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Toovey</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Prinssen</surname>
<given-names>EP</given-names>
</string-name> (<year>2014</year>) <article-title>Maternal immune activation and abnormal brain development across CNS disorders</article-title>. <source/>Nat Rev Neurol
<volume>10</volume>: <fpage>643</fpage>–<lpage>660</lpage>
<pub-id pub-id-type="pmid">25311587</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0002">
<label>2</label>
<mixed-citation id="embr201642586-cit-0002" publication-type="journal">
<string-name>
<surname>Estes</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>McAllister</surname>
<given-names>AK</given-names>
</string-name> (<year>2015</year>) <article-title>Immune mediators in the brain and peripheral tissues in autism spectrum disorder</article-title>. <source/>Nat Rev Neurosci
<volume>16</volume>: <fpage>469</fpage>–<lpage>486</lpage>
<pub-id pub-id-type="pmid">26189694</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0003">
<label>3</label>
<mixed-citation id="embr201642586-cit-0003" publication-type="journal">
<string-name>
<surname>Khandaker</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Cousins</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Deakin</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lennox</surname>
<given-names>BR</given-names>
</string-name>, <string-name>
<surname>Yolken</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Jones</surname>
<given-names>PB</given-names>
</string-name> (<year>2015</year>) <article-title>Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment</article-title>. <source/>Lancet Psychiatry
<volume>2</volume>: <fpage>258</fpage>–<lpage>270</lpage>
<pub-id pub-id-type="pmid">26359903</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0004">
<label>4</label>
<mixed-citation id="embr201642586-cit-0004" publication-type="journal">
<string-name>
<surname>Jin</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Flavell</surname>
<given-names>RA</given-names>
</string-name> (<year>2013</year>) <article-title>Innate sensors of pathogen and stress: linking inflammation to obesity</article-title>. <source/>J Allergy Clin Immunol
<volume>132</volume>: <fpage>287</fpage>–<lpage>294</lpage>
<pub-id pub-id-type="pmid">23905917</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0005">
<label>5</label>
<mixed-citation id="embr201642586-cit-0005" publication-type="journal">
<string-name>
<surname>Kawai</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Akira</surname>
<given-names>S</given-names>
</string-name> (<year>2010</year>) <article-title>The role of pattern‐recognition receptors in innate immunity: update on Toll‐like receptors</article-title>. <source/>Nat Immunol
<volume>11</volume>: <fpage>373</fpage>–<lpage>384</lpage>
<pub-id pub-id-type="pmid">20404851</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0006">
<label>6</label>
<mixed-citation id="embr201642586-cit-0006" publication-type="journal">
<string-name>
<surname>Takeuchi</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Akira</surname>
<given-names>S</given-names>
</string-name> (<year>2010</year>) <article-title>Pattern recognition receptors and inflammation</article-title>. <source/>Cell
<volume>140</volume>: <fpage>805</fpage>–<lpage>820</lpage>
<pub-id pub-id-type="pmid">20303872</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0007">
<label>7</label>
<mixed-citation id="embr201642586-cit-0007" publication-type="journal">
<string-name>
<surname>Zohaib</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Sarfraz</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kaleem</surname>
<given-names>QM</given-names>
</string-name>, <string-name>
<surname>Ye</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Mughal</surname>
<given-names>MN</given-names>
</string-name>, <string-name>
<surname>Navid</surname>
<given-names>MT</given-names>
</string-name>, <string-name>
<surname>Khan</surname>
<given-names>FA</given-names>
</string-name>, <string-name>
<surname>Duan</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Wan</surname>
<given-names>S</given-names>
</string-name>
<italic>et al</italic> (<year>2016</year>) <article-title>The Yin and Yang of antiviral innate immunity in central nervous system</article-title>. <source/>Curr Pharm Des
<volume>22</volume>: <fpage>648</fpage>–<lpage>655</lpage>
<pub-id pub-id-type="pmid">26635264</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0008">
<label>8</label>
<mixed-citation id="embr201642586-cit-0008" publication-type="journal">
<string-name>
<surname>Kawai</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Akira</surname>
<given-names>S</given-names>
</string-name> (<year>2011</year>) <article-title>Toll‐like receptors and their crosstalk with other innate receptors in infection and immunity</article-title>. <source/>Immunity
<volume>34</volume>: <fpage>637</fpage>–<lpage>650</lpage>
<pub-id pub-id-type="pmid">21616434</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0009">
<label>9</label>
<mixed-citation id="embr201642586-cit-0009" publication-type="journal">
<string-name>
<surname>Czirr</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Wyss‐Coray</surname>
<given-names>T</given-names>
</string-name> (<year>2012</year>) <article-title>The immunology of neurodegeneration</article-title>. <source/>J Clin Invest
<volume>122</volume>: <fpage>1156</fpage>–<lpage>1163</lpage>
<pub-id pub-id-type="pmid">22466657</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0010">
<label>10</label>
<mixed-citation id="embr201642586-cit-0010" publication-type="journal">
<string-name>
<surname>Cavassani</surname>
<given-names>KA</given-names>
</string-name>, <string-name>
<surname>Ishii</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wen</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Schaller</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Lincoln</surname>
<given-names>PM</given-names>
</string-name>, <string-name>
<surname>Lukacs</surname>
<given-names>NW</given-names>
</string-name>, <string-name>
<surname>Hogaboam</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Kunkel</surname>
<given-names>SL</given-names>
</string-name> (<year>2008</year>) <article-title>TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events</article-title>. <source/>J Exp Med
<volume>205</volume>: <fpage>2609</fpage>–<lpage>2621</lpage>
<pub-id pub-id-type="pmid">18838547</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0011">
<label>11</label>
<mixed-citation id="embr201642586-cit-0011" publication-type="journal">
<string-name>
<surname>Green</surname>
<given-names>NM</given-names>
</string-name>, <string-name>
<surname>Moody</surname>
<given-names>KS</given-names>
</string-name>, <string-name>
<surname>Debatis</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Marshak‐Rothstein</surname>
<given-names>A</given-names>
</string-name> (<year>2012</year>) <article-title>Activation of autoreactive B cells by endogenous TLR7 and TLR3 RNA ligands</article-title>. <source/>J Biol Chem
<volume>287</volume>: <fpage>39789</fpage>–<lpage>39799</lpage>
<pub-id pub-id-type="pmid">23019335</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0012">
<label>12</label>
<mixed-citation id="embr201642586-cit-0012" publication-type="journal">
<string-name>
<surname>Kariko</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Ni</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Capodici</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lamphier</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Weissman</surname>
<given-names>D</given-names>
</string-name> (<year>2004</year>) <article-title>mRNA is an endogenous ligand for Toll‐like receptor 3</article-title>. <source/>J Biol Chem
<volume>279</volume>: <fpage>12542</fpage>–<lpage>12550</lpage>
<pub-id pub-id-type="pmid">14729660</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0013">
<label>13</label>
<mixed-citation id="embr201642586-cit-0013" publication-type="journal">
<string-name>
<surname>Carty</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Reinert</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Paludan</surname>
<given-names>SR</given-names>
</string-name>, <string-name>
<surname>Bowie</surname>
<given-names>AG</given-names>
</string-name> (<year>2014</year>) <article-title>Innate antiviral signalling in the central nervous system</article-title>. <source/>Trends Immunol
<volume>35</volume>: <fpage>79</fpage>–<lpage>87</lpage>
<pub-id pub-id-type="pmid">24316012</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0014">
<label>14</label>
<mixed-citation id="embr201642586-cit-0014" publication-type="journal">
<string-name>
<surname>Lathia</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Okun</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Tang</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Griffioen</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Cheng</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Mughal</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Laryea</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Selvaraj</surname>
<given-names>PK</given-names>
</string-name>, <string-name>
<surname>ffrench‐Constant</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Magnus</surname>
<given-names>T</given-names>
</string-name>
<italic>et al</italic> (<year>2008</year>) <article-title>Toll‐like receptor 3 is a negative regulator of embryonic neural progenitor cell proliferation</article-title>. <source/>J Neurosci
<volume>28</volume>: <fpage>13978</fpage>–<lpage>13984</lpage>
<pub-id pub-id-type="pmid">19091986</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0015">
<label>15</label>
<mixed-citation id="embr201642586-cit-0015" publication-type="journal">
<string-name>
<surname>Cameron</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Alexopoulou</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Sloane</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>DiBernardo</surname>
<given-names>AB</given-names>
</string-name>, <string-name>
<surname>Ma</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Kosaras</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Flavell</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Strittmatter</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Volpe</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Sidman</surname>
<given-names>R</given-names>
</string-name>
<italic>et al</italic> (<year>2007</year>) <article-title>Toll‐like receptor 3 is a potent negative regulator of axonal growth in mammals</article-title>. <source/>J Neurosci
<volume>27</volume>: <fpage>13033</fpage>–<lpage>13041</lpage>
<pub-id pub-id-type="pmid">18032677</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0016">
<label>16</label>
<mixed-citation id="embr201642586-cit-0016" publication-type="journal">
<string-name>
<surname>Majidi</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kosari‐Nasab</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Salari</surname>
<given-names>AA</given-names>
</string-name> (<year>2016</year>) <article-title>Developmental minocycline treatment reverses the effects of neonatal immune activation on anxiety‐ and depression‐like behaviors, hippocampal inflammation, and HPA axis activity in adult mice</article-title>. <source/>Brain Res Bull
<volume>120</volume>: <fpage>1</fpage>–<lpage>13</lpage>
<pub-id pub-id-type="pmid">26521068</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0017">
<label>17</label>
<mixed-citation id="embr201642586-cit-0017" publication-type="journal">
<string-name>
<surname>Okun</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Griffioen</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Barak</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Roberts</surname>
<given-names>NJ</given-names>
</string-name>, <string-name>
<surname>Castro</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Pita</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Cheng</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Mughal</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Wan</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Ashery</surname>
<given-names>U</given-names>
</string-name>
<italic>et al</italic> (<year>2010</year>) <article-title>Toll‐like receptor 3 inhibits memory retention and constrains adult hippocampal neurogenesis</article-title>. <source/>Proc Natl Acad Sci USA
<volume>107</volume>: <fpage>15625</fpage>–<lpage>15630</lpage>
<pub-id pub-id-type="pmid">20713712</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0018">
<label>18</label>
<mixed-citation id="embr201642586-cit-0018" publication-type="journal">
<string-name>
<surname>Choi</surname>
<given-names>GB</given-names>
</string-name>, <string-name>
<surname>Yim</surname>
<given-names>YS</given-names>
</string-name>, <string-name>
<surname>Wong</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>SV</given-names>
</string-name>, <string-name>
<surname>Hoeffer</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Littman</surname>
<given-names>DR</given-names>
</string-name>, <string-name>
<surname>Huh</surname>
<given-names>JR</given-names>
</string-name> (<year>2016</year>) <article-title>The maternal interleukin‐17a pathway in mice promotes autism‐like phenotypes in offspring</article-title>. <source/>Science
<volume>351</volume>: <fpage>933</fpage>–<lpage>939</lpage>
<pub-id pub-id-type="pmid">26822608</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0019">
<label>19</label>
<mixed-citation id="embr201642586-cit-0019" publication-type="journal">
<string-name>
<surname>Smith</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Garbett</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Mirnics</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Patterson</surname>
<given-names>PH</given-names>
</string-name> (<year>2007</year>) <article-title>Maternal immune activation alters fetal brain development through interleukin‐6</article-title>. <source/>J Neurosci
<volume>27</volume>: <fpage>10695</fpage>–<lpage>10702</lpage>
<pub-id pub-id-type="pmid">17913903</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0020">
<label>20</label>
<mixed-citation id="embr201642586-cit-0020" publication-type="journal">
<string-name>
<surname>Liu</surname>
<given-names>HY</given-names>
</string-name>, <string-name>
<surname>Hong</surname>
<given-names>YF</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>CY</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>TN</given-names>
</string-name>, <string-name>
<surname>Hsueh</surname>
<given-names>YP</given-names>
</string-name> (<year>2013</year>) <article-title>TLR7 negatively regulates dendrite outgrowth through the Myd88‐c‐Fos‐IL‐6 pathway</article-title>. <source/>J Neurosci
<volume>33</volume>: <fpage>11479</fpage>–<lpage>11493</lpage>
<pub-id pub-id-type="pmid">23843519</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0021">
<label>21</label>
<mixed-citation id="embr201642586-cit-0021" publication-type="journal">
<string-name>
<surname>Liu</surname>
<given-names>HY</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>CY</given-names>
</string-name>, <string-name>
<surname>Hsueh</surname>
<given-names>YP</given-names>
</string-name> (<year>2014</year>) <article-title>Innate immune responses regulate morphogenesis and degeneration: roles of Toll‐like receptors and Sarm1 in neurons</article-title>. <source/>Neurosci Bull
<volume>30</volume>: <fpage>645</fpage>–<lpage>654</lpage>
<pub-id pub-id-type="pmid">24993772</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0022">
<label>22</label>
<mixed-citation id="embr201642586-cit-0022" publication-type="journal">
<string-name>
<surname>Liu</surname>
<given-names>HY</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Hung</surname>
<given-names>YF</given-names>
</string-name>, <string-name>
<surname>Hsueh</surname>
<given-names>YP</given-names>
</string-name> (<year>2015</year>) <article-title>The microRNAs Let7c and miR21 are recognized by neuronal Toll‐like receptor 7 to restrict dendritic growth of neurons</article-title>. <source/>Exp Neurol
<volume>269</volume>: <fpage>202</fpage>–<lpage>212</lpage>
<pub-id pub-id-type="pmid">25917529</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0023">
<label>23</label>
<mixed-citation id="embr201642586-cit-0023" publication-type="journal">
<string-name>
<surname>Hoebe</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Du</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Georgel</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Janssen</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Tabeta</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>SO</given-names>
</string-name>, <string-name>
<surname>Goode</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Mann</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Mudd</surname>
<given-names>S</given-names>
</string-name>
<italic>et al</italic> (<year>2003</year>) <article-title>Identification of Lps2 as a key transducer of MyD88‐independent TIR signalling</article-title>. <source/>Nature
<volume>424</volume>: <fpage>743</fpage>–<lpage>748</lpage>
<pub-id pub-id-type="pmid">12872135</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0024">
<label>24</label>
<mixed-citation id="embr201642586-cit-0024" publication-type="journal">
<string-name>
<surname>Hou</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Reizis</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>DeFranco</surname>
<given-names>AL</given-names>
</string-name> (<year>2008</year>) <article-title>Toll‐like receptors activate innate and adaptive immunity by using dendritic cell‐intrinsic and ‐extrinsic mechanisms</article-title>. <source/>Immunity
<volume>29</volume>: <fpage>272</fpage>–<lpage>282</lpage>
<pub-id pub-id-type="pmid">18656388</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0025">
<label>25</label>
<mixed-citation id="embr201642586-cit-0025" publication-type="journal">
<string-name>
<surname>Kawai</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Akira</surname>
<given-names>S</given-names>
</string-name> (<year>2006</year>) <article-title>TLR signaling</article-title>. <source/>Cell Death Differ
<volume>13</volume>: <fpage>816</fpage>–<lpage>825</lpage>
<pub-id pub-id-type="pmid">16410796</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0026">
<label>26</label>
<mixed-citation id="embr201642586-cit-0026" publication-type="journal">
<string-name>
<surname>Ohnishi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Tochio</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kato</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Orii</surname>
<given-names>KE</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kimura</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hiroaki</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kondo</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Shirakawa</surname>
<given-names>M</given-names>
</string-name> (<year>2009</year>) <article-title>Structural basis for the multiple interactions of the MyD88 TIR domain in TLR4 signaling</article-title>. <source/>Proc Natl Acad Sci USA
<volume>106</volume>: <fpage>10260</fpage>–<lpage>10265</lpage>
<pub-id pub-id-type="pmid">19506249</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0027">
<label>27</label>
<mixed-citation id="embr201642586-cit-0027" publication-type="journal">
<string-name>
<surname>Lin</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Lo</surname>
<given-names>YC</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>H</given-names>
</string-name> (<year>2010</year>) <article-title>Helical assembly in the MyD88‐IRAK4‐IRAK2 complex in TLR/IL‐1R signalling</article-title>. <source/>Nature
<volume>465</volume>: <fpage>885</fpage>–<lpage>890</lpage>
<pub-id pub-id-type="pmid">20485341</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0028">
<label>28</label>
<mixed-citation id="embr201642586-cit-0028" publication-type="journal">
<string-name>
<surname>Into</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Inomata</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Niida</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Murakami</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Shibata</surname>
<given-names>K</given-names>
</string-name> (<year>2010</year>) <article-title>Regulation of MyD88 aggregation and the MyD88‐dependent signaling pathway by sequestosome 1 and histone deacetylase 6</article-title>. <source/>J Biol Chem
<volume>285</volume>: <fpage>35759</fpage>–<lpage>35769</lpage>
<pub-id pub-id-type="pmid">20837465</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0029">
<label>29</label>
<mixed-citation id="embr201642586-cit-0029" publication-type="journal">
<string-name>
<surname>Gilmore</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Fredrik Jarskog</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Vadlamudi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Lauder</surname>
<given-names>JM</given-names>
</string-name> (<year>2004</year>) <article-title>Prenatal infection and risk for schizophrenia: IL‐1beta, IL‐6, and TNFalpha inhibit cortical neuron dendrite development</article-title>. <source/>Neuropsychopharmacology
<volume>29</volume>: <fpage>1221</fpage>–<lpage>1229</lpage>
<pub-id pub-id-type="pmid">15085088</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0030">
<label>30</label>
<mixed-citation id="embr201642586-cit-0030" publication-type="journal">
<string-name>
<surname>Chen</surname>
<given-names>CY</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>CW</given-names>
</string-name>, <string-name>
<surname>Chang</surname>
<given-names>CY</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>ST</given-names>
</string-name>, <string-name>
<surname>Hsueh</surname>
<given-names>YP</given-names>
</string-name> (<year>2011</year>) <article-title>Sarm1, a negative regulator of innate immunity, interacts with syndecan‐2 and regulates neuronal morphology</article-title>. <source/>J Cell Biol
<volume>193</volume>: <fpage>769</fpage>–<lpage>784</lpage>
<pub-id pub-id-type="pmid">21555464</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0031">
<label>31</label>
<mixed-citation id="embr201642586-cit-0031" publication-type="journal">
<string-name>
<surname>Bsibsi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Bajramovic</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Vogt</surname>
<given-names>MH</given-names>
</string-name>, <string-name>
<surname>van Duijvenvoorden</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Baghat</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Persoon‐Deen</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Tielen</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Verbeek</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Huitinga</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Ryffel</surname>
<given-names>B</given-names>
</string-name>
<italic>et al</italic> (<year>2010</year>) <article-title>The microtubule regulator stathmin is an endogenous protein agonist for TLR3</article-title>. <source/>J Immunol
<volume>184</volume>: <fpage>6929</fpage>–<lpage>6937</lpage>
<pub-id pub-id-type="pmid">20483774</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0032">
<label>32</label>
<mixed-citation id="embr201642586-cit-0032" publication-type="journal">
<string-name>
<surname>Patterson</surname>
<given-names>PH</given-names>
</string-name> (<year>2011</year>) <article-title>Maternal infection and immune involvement in autism</article-title>. <source/>Trends Mol Med
<volume>17</volume>: <fpage>389</fpage>–<lpage>394</lpage>
<pub-id pub-id-type="pmid">21482187</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0033">
<label>33</label>
<mixed-citation id="embr201642586-cit-0033" publication-type="journal">
<string-name>
<surname>Singh</surname>
<given-names>KK</given-names>
</string-name>, <string-name>
<surname>De Rienzo</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Drane</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Mao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Flood</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Madison</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ferreira</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Bergen</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>King</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Sklar</surname>
<given-names>P</given-names>
</string-name>
<italic>et al</italic> (<year>2011</year>) <article-title>Common DISC1 polymorphisms disrupt Wnt/GSK3beta signaling and brain development</article-title>. <source/>Neuron
<volume>72</volume>: <fpage>545</fpage>–<lpage>558</lpage>
<pub-id pub-id-type="pmid">22099458</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0034">
<label>34</label>
<mixed-citation id="embr201642586-cit-0034" publication-type="journal">
<string-name>
<surname>Malavasi</surname>
<given-names>EL</given-names>
</string-name>, <string-name>
<surname>Ogawa</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Porteous</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Millar</surname>
<given-names>JK</given-names>
</string-name> (<year>2012</year>) <article-title>DISC1 variants 37W and 607F disrupt its nuclear targeting and regulatory role in ATF4‐mediated transcription</article-title>. <source/>Hum Mol Genet
<volume>21</volume>: <fpage>2779</fpage>–<lpage>2792</lpage>
<pub-id pub-id-type="pmid">22422769</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0035">
<label>35</label>
<mixed-citation id="embr201642586-cit-0035" publication-type="journal">
<string-name>
<surname>O'Neill</surname>
<given-names>LA</given-names>
</string-name>, <string-name>
<surname>Golenbock</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Bowie</surname>
<given-names>AG</given-names>
</string-name> (<year>2013</year>) <article-title>The history of Toll‐like receptors – redefining innate immunity</article-title>. <source/>Nat Rev Immunol
<volume>13</volume>: <fpage>453</fpage>–<lpage>460</lpage>
<pub-id pub-id-type="pmid">23681101</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0036">
<label>36</label>
<mixed-citation id="embr201642586-cit-0036" publication-type="journal">
<string-name>
<surname>Yamamoto</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sato</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hemmi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Hoshino</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kaisho</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Sanjo</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Takeuchi</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Sugiyama</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Okabe</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Takeda</surname>
<given-names>K</given-names>
</string-name>
<italic>et al</italic> (<year>2003</year>) <article-title>Role of adaptor TRIF in the MyD88‐independent toll‐like receptor signaling pathway</article-title>. <source/>Science
<volume>301</volume>: <fpage>640</fpage>–<lpage>643</lpage>
<pub-id pub-id-type="pmid">12855817</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0037">
<label>37</label>
<mixed-citation id="embr201642586-cit-0037" publication-type="journal">
<string-name>
<surname>Choi</surname>
<given-names>YJ</given-names>
</string-name>, <string-name>
<surname>Im</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Chung</surname>
<given-names>HK</given-names>
</string-name>, <string-name>
<surname>Pothoulakis</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Rhee</surname>
<given-names>SH</given-names>
</string-name> (<year>2010</year>) <article-title>TRIF mediates Toll‐like receptor 5‐induced signaling in intestinal epithelial cells</article-title>. <source/>J Biol Chem
<volume>285</volume>: <fpage>37570</fpage>–<lpage>37578</lpage>
<pub-id pub-id-type="pmid">20855887</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0038">
<label>38</label>
<mixed-citation id="embr201642586-cit-0038" publication-type="journal">
<string-name>
<surname>Volpi</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Fallarino</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Pallotta</surname>
<given-names>MT</given-names>
</string-name>, <string-name>
<surname>Bianchi</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Vacca</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Belladonna</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Orabona</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>De Luca</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Boon</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Romani</surname>
<given-names>L</given-names>
</string-name>
<italic>et al</italic> (<year>2013</year>) <article-title>High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9‐TRIF pathway</article-title>. <source/>Nat Commun
<volume>4</volume>: <fpage>1852</fpage>
<pub-id pub-id-type="pmid">23673637</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0039">
<label>39</label>
<mixed-citation id="embr201642586-cit-0039" publication-type="journal">
<string-name>
<surname>Mukherjee</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Winkler</surname>
<given-names>CW</given-names>
</string-name>, <string-name>
<surname>Taylor</surname>
<given-names>KG</given-names>
</string-name>, <string-name>
<surname>Woods</surname>
<given-names>TA</given-names>
</string-name>, <string-name>
<surname>Nair</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Khan</surname>
<given-names>BA</given-names>
</string-name>, <string-name>
<surname>Peterson</surname>
<given-names>KE</given-names>
</string-name> (<year>2015</year>) <article-title>SARM1, not MyD88, mediates TLR7/TLR9‐induced apoptosis in neurons</article-title>. <source/>J Immunol
<volume>195</volume>: <fpage>4913</fpage>–<lpage>4921</lpage>
<pub-id pub-id-type="pmid">26423149</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0040">
<label>40</label>
<mixed-citation id="embr201642586-cit-0040" publication-type="journal">
<string-name>
<surname>Zhande</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Dauphinee</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Thomas</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Yamamoto</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Akira</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Karsan</surname>
<given-names>A</given-names>
</string-name> (<year>2007</year>) <article-title>FADD negatively regulates lipopolysaccharide signaling by impairing interleukin‐1 receptor‐associated kinase 1‐MyD88 interaction</article-title>. <source/>Mol Cell Biol
<volume>27</volume>: <fpage>7394</fpage>–<lpage>7404</lpage>
<pub-id pub-id-type="pmid">17785432</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0041">
<label>41</label>
<mixed-citation id="embr201642586-cit-0041" publication-type="journal">
<string-name>
<surname>Muzio</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ni</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Feng</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Dixit</surname>
<given-names>VM</given-names>
</string-name> (<year>1997</year>) <article-title>IRAK (Pelle) family member IRAK‐2 and MyD88 as proximal mediators of IL‐1 signaling</article-title>. <source/>Science
<volume>278</volume>: <fpage>1612</fpage>–<lpage>1615</lpage>
<pub-id pub-id-type="pmid">9374458</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0042">
<label>42</label>
<mixed-citation id="embr201642586-cit-0042" publication-type="journal">
<string-name>
<surname>George</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Motshwene</surname>
<given-names>PG</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kubarenko</surname>
<given-names>AV</given-names>
</string-name>, <string-name>
<surname>Rautanen</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Mills</surname>
<given-names>TC</given-names>
</string-name>, <string-name>
<surname>Hill</surname>
<given-names>AV</given-names>
</string-name>, <string-name>
<surname>Gay</surname>
<given-names>NJ</given-names>
</string-name>, <string-name>
<surname>Weber</surname>
<given-names>AN</given-names>
</string-name> (<year>2011</year>) <article-title>Two human MYD88 variants, S34Y and R98C, interfere with MyD88‐IRAK4‐myddosome assembly</article-title>. <source/>J Biol Chem
<volume>286</volume>: <fpage>1341</fpage>–<lpage>1353</lpage>
<pub-id pub-id-type="pmid">20966070</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0043">
<label>43</label>
<mixed-citation id="embr201642586-cit-0043" publication-type="journal">
<string-name>
<surname>Kawai</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Sato</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ishii</surname>
<given-names>KJ</given-names>
</string-name>, <string-name>
<surname>Coban</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Hemmi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Yamamoto</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Terai</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Matsuda</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Inoue</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Uematsu</surname>
<given-names>S</given-names>
</string-name>
<italic>et al</italic> (<year>2004</year>) <article-title>Interferon‐alpha induction through Toll‐like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6</article-title>. <source/>Nat Immunol
<volume>5</volume>: <fpage>1061</fpage>–<lpage>1068</lpage>
<pub-id pub-id-type="pmid">15361868</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0044">
<label>44</label>
<mixed-citation id="embr201642586-cit-0044" publication-type="journal">
<string-name>
<surname>Gay</surname>
<given-names>NJ</given-names>
</string-name>, <string-name>
<surname>Symmons</surname>
<given-names>MF</given-names>
</string-name>, <string-name>
<surname>Gangloff</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Bryant</surname>
<given-names>CE</given-names>
</string-name> (<year>2014</year>) <article-title>Assembly and localization of Toll‐like receptor signalling complexes</article-title>. <source/>Nat Rev Immunol
<volume>14</volume>: <fpage>546</fpage>–<lpage>558</lpage>
<pub-id pub-id-type="pmid">25060580</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0045">
<label>45</label>
<mixed-citation id="embr201642586-cit-0045" publication-type="journal">
<string-name>
<surname>Iliev</surname>
<given-names>DB</given-names>
</string-name>, <string-name>
<surname>Sobhkhez</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Fremmerlid</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Jorgensen</surname>
<given-names>JB</given-names>
</string-name> (<year>2011</year>) <article-title>MyD88 interacts with interferon regulatory factor (IRF) 3 and IRF7 in Atlantic salmon (<italic>Salmo salar</italic>): transgenic SsMyD88 modulates the IRF‐induced type I interferon response and accumulates in aggresomes</article-title>. <source/>J Biol Chem
<volume>286</volume>: <fpage>42715</fpage>–<lpage>42724</lpage>
<pub-id pub-id-type="pmid">21990356</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0046">
<label>46</label>
<mixed-citation id="embr201642586-cit-0046" publication-type="journal">
<string-name>
<surname>O'Leary</surname>
<given-names>DR</given-names>
</string-name>, <string-name>
<surname>Kuhn</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kniss</surname>
<given-names>KL</given-names>
</string-name>, <string-name>
<surname>Hinckley</surname>
<given-names>AF</given-names>
</string-name>, <string-name>
<surname>Rasmussen</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Pape</surname>
<given-names>WJ</given-names>
</string-name>, <string-name>
<surname>Kightlinger</surname>
<given-names>LK</given-names>
</string-name>, <string-name>
<surname>Beecham</surname>
<given-names>BD</given-names>
</string-name>, <string-name>
<surname>Miller</surname>
<given-names>TK</given-names>
</string-name>, <string-name>
<surname>Neitzel</surname>
<given-names>DF</given-names>
</string-name>
<italic>et al</italic> (<year>2006</year>) <article-title>Birth outcomes following West Nile Virus infection of pregnant women in the United States: 2003–2004</article-title>. <source/>Pediatrics
<volume>117</volume>: <fpage>e537</fpage>–<lpage>e545</lpage>
<pub-id pub-id-type="pmid">16510632</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0047">
<label>47</label>
<mixed-citation id="embr201642586-cit-0047" publication-type="journal">
<string-name>
<surname>Mlakar</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Korva</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Tul</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Popovic</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Poljsak‐Prijatelj</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Mraz</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kolenc</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Resman Rus</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Vesnaver Vipotnik</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Fabjan Vodusek</surname>
<given-names>V</given-names>
</string-name>
<italic>et al</italic> (<year>2016</year>) <article-title>Zika virus associated with microcephaly</article-title>. <source/>New Engl J Med
<volume>374</volume>: <fpage>951</fpage>–<lpage>958</lpage>
<pub-id pub-id-type="pmid">26862926</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0048">
<label>48</label>
<mixed-citation id="embr201642586-cit-0048" publication-type="journal">
<string-name>
<surname>Daffis</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Samuel</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Suthar</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Gale</surname>
<given-names>M</given-names>
<suffix>Jr</suffix>
</string-name>, <string-name>
<surname>Diamond</surname>
<given-names>MS</given-names>
</string-name> (<year>2008</year>) <article-title>Toll‐like receptor 3 has a protective role against West Nile virus infection</article-title>. <source/>J Virol
<volume>82</volume>: <fpage>10349</fpage>–<lpage>10358</lpage>
<pub-id pub-id-type="pmid">18715906</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0049">
<label>49</label>
<mixed-citation id="embr201642586-cit-0049" publication-type="journal">
<string-name>
<surname>Hamel</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Dejarnac</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Wichit</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ekchariyawat</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Neyret</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Luplertlop</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Perera‐Lecoin</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Surasombatpattana</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Talignani</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Thomas</surname>
<given-names>F</given-names>
</string-name>
<italic>et al</italic> (<year>2015</year>) <article-title>Biology of Zika virus infection in human skin cells</article-title>. <source/>J Virol
<volume>89</volume>: <fpage>8880</fpage>–<lpage>8896</lpage>
<pub-id pub-id-type="pmid">26085147</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0050">
<label>50</label>
<mixed-citation id="embr201642586-cit-0050" publication-type="journal">
<string-name>
<surname>Town</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Jeng</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Alexopoulou</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Tan</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Flavell</surname>
<given-names>RA</given-names>
</string-name> (<year>2006</year>) <article-title>Microglia recognize double‐stranded RNA via TLR3</article-title>. <source/>J Immunol
<volume>176</volume>: <fpage>3804</fpage>–<lpage>3812</lpage>
<pub-id pub-id-type="pmid">16517751</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0051">
<label>51</label>
<mixed-citation id="embr201642586-cit-0051" publication-type="journal">
<string-name>
<surname>Blackwood</surname>
<given-names>DH</given-names>
</string-name>, <string-name>
<surname>Fordyce</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Walker</surname>
<given-names>MT</given-names>
</string-name>, <string-name>
<surname>St Clair</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Porteous</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Muir</surname>
<given-names>WJ</given-names>
</string-name> (<year>2001</year>) <article-title>Schizophrenia and affective disorders–cosegregation with a translocation at chromosome 1q42 that directly disrupts brain‐expressed genes: clinical and P300 findings in a family</article-title>. <source/>Am J Hum Genet
<volume>69</volume>: <fpage>428</fpage>–<lpage>433</lpage>
<pub-id pub-id-type="pmid">11443544</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0052">
<label>52</label>
<mixed-citation id="embr201642586-cit-0052" publication-type="journal">
<string-name>
<surname>Millar</surname>
<given-names>JK</given-names>
</string-name>, <string-name>
<surname>Wilson‐Annan</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Anderson</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Christie</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Taylor</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Semple</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Devon</surname>
<given-names>RS</given-names>
</string-name>, <string-name>
<surname>St Clair</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Muir</surname>
<given-names>WJ</given-names>
</string-name>, <string-name>
<surname>Blackwood</surname>
<given-names>DH</given-names>
</string-name>
<italic>et al</italic> (<year>2000</year>) <article-title>Disruption of two novel genes by a translocation co‐segregating with schizophrenia</article-title>. <source/>Hum Mol Genet
<volume>9</volume>: <fpage>1415</fpage>–<lpage>1423</lpage>
<pub-id pub-id-type="pmid">10814723</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0053">
<label>53</label>
<mixed-citation id="embr201642586-cit-0053" publication-type="journal">
<string-name>
<surname>Kilpinen</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ylisaukko‐Oja</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hennah</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Palo</surname>
<given-names>OM</given-names>
</string-name>, <string-name>
<surname>Varilo</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Vanhala</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Nieminen‐von Wendt</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>von Wendt</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Paunio</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Peltonen</surname>
<given-names>L</given-names>
</string-name> (<year>2008</year>) <article-title>Association of DISC1 with autism and Asperger syndrome</article-title>. <source/>Mol Psychiatry
<volume>13</volume>: <fpage>187</fpage>–<lpage>196</lpage>
<pub-id pub-id-type="pmid">17579608</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0054">
<label>54</label>
<mixed-citation id="embr201642586-cit-0054" publication-type="journal">
<string-name>
<surname>Zheng</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Jia</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Yue</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Ruan</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>D</given-names>
</string-name> (<year>2011</year>) <article-title>Evidence for association between Disrupted‐in‐Schizophrenia 1 (DISC1) gene polymorphisms and autism in Chinese Han population: a family‐based association study</article-title>. <source/>Behav Brain Funct
<volume>7</volume>: <fpage>14</fpage>
<pub-id pub-id-type="pmid">21569632</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0055">
<label>55</label>
<mixed-citation id="embr201642586-cit-0055" publication-type="journal">
<string-name>
<surname>Chubb</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Bradshaw</surname>
<given-names>NJ</given-names>
</string-name>, <string-name>
<surname>Soares</surname>
<given-names>DC</given-names>
</string-name>, <string-name>
<surname>Porteous</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Millar</surname>
<given-names>JK</given-names>
</string-name> (<year>2008</year>) <article-title>The DISC locus in psychiatric illness</article-title>. <source/>Mol Psychiatry
<volume>13</volume>: <fpage>36</fpage>–<lpage>64</lpage>
<pub-id pub-id-type="pmid">17912248</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0056">
<label>56</label>
<mixed-citation id="embr201642586-cit-0056" publication-type="journal">
<string-name>
<surname>Brandon</surname>
<given-names>NJ</given-names>
</string-name>, <string-name>
<surname>Sawa</surname>
<given-names>A</given-names>
</string-name> (<year>2011</year>) <article-title>Linking neurodevelopmental and synaptic theories of mental illness through DISC1</article-title>. <source/>Nat Rev Neurosci
<volume>12</volume>: <fpage>707</fpage>–<lpage>722</lpage>
<pub-id pub-id-type="pmid">22095064</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0057">
<label>57</label>
<mixed-citation id="embr201642586-cit-0057" publication-type="journal">
<string-name>
<surname>Hattori</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Shimizu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Koyama</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yamada</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kuwahara</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Kumamoto</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Matsuzaki</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ito</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Katayama</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Tohyama</surname>
<given-names>M</given-names>
</string-name> (<year>2010</year>) <article-title>DISC1 regulates cell‐cell adhesion, cell‐matrix adhesion and neurite outgrowth</article-title>. <source/>Mol Psychiatry
<volume>15</volume>: <fpage>778</fpage> 798–809<pub-id pub-id-type="pmid">20479754</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0058">
<label>58</label>
<mixed-citation id="embr201642586-cit-0058" publication-type="journal">
<string-name>
<surname>Lee</surname>
<given-names>FH</given-names>
</string-name>, <string-name>
<surname>Fadel</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Preston‐Maher</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Cordes</surname>
<given-names>SP</given-names>
</string-name>, <string-name>
<surname>Clapcote</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Price</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Roder</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Wong</surname>
<given-names>AH</given-names>
</string-name> (<year>2011</year>) <article-title>Disc1 point mutations in mice affect development of the cerebral cortex</article-title>. <source/>J Neurosci
<volume>31</volume>: <fpage>3197</fpage>–<lpage>3206</lpage>
<pub-id pub-id-type="pmid">21368031</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0059">
<label>59</label>
<mixed-citation id="embr201642586-cit-0059" publication-type="journal">
<string-name>
<surname>Tsuboi</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Kuroda</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Tanaka</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Namba</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Iizuka</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Taya</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Shinoda</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hikita</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Muraoka</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Iizuka</surname>
<given-names>M</given-names>
</string-name>
<italic>et al</italic> (<year>2015</year>) <article-title>Disrupted‐in‐schizophrenia 1 regulates transport of ITPR1 mRNA for synaptic plasticity</article-title>. <source/>Nat Neurosci
<volume>18</volume>: <fpage>698</fpage>–<lpage>707</lpage>
<pub-id pub-id-type="pmid">25821909</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0060">
<label>60</label>
<mixed-citation id="embr201642586-cit-0060" publication-type="journal">
<string-name>
<surname>Camargo</surname>
<given-names>LM</given-names>
</string-name>, <string-name>
<surname>Collura</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Rain</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Mizuguchi</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Hermjakob</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kerrien</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Bonnert</surname>
<given-names>TP</given-names>
</string-name>, <string-name>
<surname>Whiting</surname>
<given-names>PJ</given-names>
</string-name>, <string-name>
<surname>Brandon</surname>
<given-names>NJ</given-names>
</string-name> (<year>2007</year>) <article-title>Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia</article-title>. <source/>Mol Psychiatry
<volume>12</volume>: <fpage>74</fpage>–<lpage>86</lpage>
<pub-id pub-id-type="pmid">17043677</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0061">
<label>61</label>
<mixed-citation id="embr201642586-cit-0061" publication-type="journal">
<string-name>
<surname>Shu</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ayala</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Nguyen</surname>
<given-names>MD</given-names>
</string-name>, <string-name>
<surname>Xie</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Gleeson</surname>
<given-names>JG</given-names>
</string-name>, <string-name>
<surname>Tsai</surname>
<given-names>LH</given-names>
</string-name> (<year>2004</year>) <article-title>Ndel1 operates in a common pathway with LIS1 and cytoplasmic dynein to regulate cortical neuronal positioning</article-title>. <source/>Neuron
<volume>44</volume>: <fpage>263</fpage>–<lpage>277</lpage>
<pub-id pub-id-type="pmid">15473966</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0062">
<label>62</label>
<mixed-citation id="embr201642586-cit-0062" publication-type="journal">
<string-name>
<surname>Morris</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Kandpal</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Ma</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Austin</surname>
<given-names>CP</given-names>
</string-name> (<year>2003</year>) <article-title>DISC1 (Disrupted‐In‐Schizophrenia 1) is a centrosome‐associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation</article-title>. <source/>Hum Mol Genet
<volume>12</volume>: <fpage>1591</fpage>–<lpage>1608</lpage>
<pub-id pub-id-type="pmid">12812986</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0063">
<label>63</label>
<mixed-citation id="embr201642586-cit-0063" publication-type="journal">
<string-name>
<surname>Taya</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Shinoda</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Tsuboi</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Asaki</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Nagai</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Hikita</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kuroda</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kuroda</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Shimizu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hirotsune</surname>
<given-names>S</given-names>
</string-name>
<italic>et al</italic> (<year>2007</year>) <article-title>DISC1 regulates the transport of the NUDEL/LIS1/14‐3‐3epsilon complex through kinesin‐1</article-title>. <source/>J Neurosci
<volume>27</volume>: <fpage>15</fpage>–<lpage>26</lpage>
<pub-id pub-id-type="pmid">17202468</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0064">
<label>64</label>
<mixed-citation id="embr201642586-cit-0064" publication-type="journal">
<string-name>
<surname>Shinoda</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Taya</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Tsuboi</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Hikita</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Matsuzawa</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Kuroda</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Iwamatsu</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kaibuchi</surname>
<given-names>K</given-names>
</string-name> (<year>2007</year>) <article-title>DISC1 regulates neurotrophin‐induced axon elongation via interaction with Grb2</article-title>. <source/>J Neurosci
<volume>27</volume>: <fpage>4</fpage>–<lpage>14</lpage>
<pub-id pub-id-type="pmid">17202467</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0065">
<label>65</label>
<mixed-citation id="embr201642586-cit-0065" publication-type="journal">
<string-name>
<surname>Ehninger</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Sano</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>de Vries</surname>
<given-names>PJ</given-names>
</string-name>, <string-name>
<surname>Dies</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Franz</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Geschwind</surname>
<given-names>DH</given-names>
</string-name>, <string-name>
<surname>Kaur</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>YS</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Lowe</surname>
<given-names>JK</given-names>
</string-name>
<italic>et al</italic> (<year>2012</year>) <article-title>Gestational immune activation and Tsc2 haploinsufficiency cooperate to disrupt fetal survival and may perturb social behavior in adult mice</article-title>. <source/>Mol Psychiatry
<volume>17</volume>: <fpage>62</fpage>–<lpage>70</lpage>
<pub-id pub-id-type="pmid">21079609</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0066">
<label>66</label>
<mixed-citation id="embr201642586-cit-0066" publication-type="journal">
<string-name>
<surname>Abazyan</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Nomura</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kannan</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Ishizuka</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Tamashiro</surname>
<given-names>KL</given-names>
</string-name>, <string-name>
<surname>Nucifora</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Pogorelov</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Ladenheim</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Krasnova</surname>
<given-names>IN</given-names>
</string-name>
<italic>et al</italic> (<year>2010</year>) <article-title>Prenatal interaction of mutant DISC1 and immune activation produces adult psychopathology</article-title>. <source/>Biol Psychiatry
<volume>68</volume>: <fpage>1172</fpage>–<lpage>1181</lpage>
<pub-id pub-id-type="pmid">21130225</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0067">
<label>67</label>
<mixed-citation id="embr201642586-cit-0067" publication-type="journal">
<string-name>
<surname>Nagai</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kitahara</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Ibi</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Nabeshima</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Sawa</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Yamada</surname>
<given-names>K</given-names>
</string-name> (<year>2011</year>) <article-title>Effects of antipsychotics on the behavioral deficits in human dominant‐negative DISC1 transgenic mice with neonatal polyI: C treatment</article-title>. <source/>Behav Brain Res
<volume>225</volume>: <fpage>305</fpage>–<lpage>310</lpage>
<pub-id pub-id-type="pmid">21835207</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0068">
<label>68</label>
<mixed-citation id="embr201642586-cit-0068" publication-type="journal">
<string-name>
<surname>Lipina</surname>
<given-names>TV</given-names>
</string-name>, <string-name>
<surname>Zai</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Hlousek</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Roder</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Wong</surname>
<given-names>AH</given-names>
</string-name> (<year>2013</year>) <article-title>Maternal immune activation during gestation interacts with Disc1 point mutation to exacerbate schizophrenia‐related behaviors in mice</article-title>. <source/>J Neurosci
<volume>33</volume>: <fpage>7654</fpage>–<lpage>7666</lpage>
<pub-id pub-id-type="pmid">23637159</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0069">
<label>69</label>
<mixed-citation id="embr201642586-cit-0069" publication-type="journal">
<string-name>
<surname>Penzes</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Cahill</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Jones</surname>
<given-names>KA</given-names>
</string-name>, <string-name>
<surname>VanLeeuwen</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Woolfrey</surname>
<given-names>KM</given-names>
</string-name> (<year>2011</year>) <article-title>Dendritic spine pathology in neuropsychiatric disorders</article-title>. <source/>Nat Neurosci
<volume>14</volume>: <fpage>285</fpage>–<lpage>293</lpage>
<pub-id pub-id-type="pmid">21346746</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0070">
<label>70</label>
<mixed-citation id="embr201642586-cit-0070" publication-type="journal">
<string-name>
<surname>Henderson</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Wijetunge</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Kinoshita</surname>
<given-names>MN</given-names>
</string-name>, <string-name>
<surname>Shumway</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hammond</surname>
<given-names>RS</given-names>
</string-name>, <string-name>
<surname>Postma</surname>
<given-names>FR</given-names>
</string-name>, <string-name>
<surname>Brynczka</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Rush</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Thomas</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Paylor</surname>
<given-names>R</given-names>
</string-name>
<italic>et al</italic> (<year>2012</year>) <article-title>Reversal of disease‐related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofen</article-title>. <source/>Sci Transl Med
<volume>4</volume>: <fpage>152ra128</fpage>
</mixed-citation>
</ref>
<ref id="embr201642586-bib-0071">
<label>71</label>
<mixed-citation id="embr201642586-cit-0071" publication-type="journal">
<string-name>
<surname>Netea</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Joosten</surname>
<given-names>LA</given-names>
</string-name>, <string-name>
<surname>Latz</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Mills</surname>
<given-names>KH</given-names>
</string-name>, <string-name>
<surname>Natoli</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Stunnenberg</surname>
<given-names>HG</given-names>
</string-name>, <string-name>
<surname>O'Neill</surname>
<given-names>LA</given-names>
</string-name>, <string-name>
<surname>Xavier</surname>
<given-names>RJ</given-names>
</string-name> (<year>2016</year>) <article-title>Trained immunity: a program of innate immune memory in health and disease</article-title>. <source/>Science
<volume>352</volume>: <fpage>aaf1098</fpage>
<pub-id pub-id-type="pmid">27102489</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0072">
<label>72</label>
<mixed-citation id="embr201642586-cit-0072" publication-type="journal">
<string-name>
<surname>Ibi</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Nagai</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kitahara</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Mizoguchi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Koike</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Shiraki</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Takuma</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kamei</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Noda</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Nitta</surname>
<given-names>A</given-names>
</string-name>
<italic>et al</italic> (<year>2009</year>) <article-title>Neonatal polyI: C treatment in mice results in schizophrenia‐like behavioral and neurochemical abnormalities in adulthood</article-title>. <source/>Neurosci Res
<volume>64</volume>: <fpage>297</fpage>–<lpage>305</lpage>
<pub-id pub-id-type="pmid">19447299</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0073">
<label>73</label>
<mixed-citation id="embr201642586-cit-0073" publication-type="journal">
<string-name>
<surname>Kuroda</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Yamada</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Tanaka</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Iizuka</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Yano</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Mori</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Tsuboi</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Nishioka</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Namba</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Iizuka</surname>
<given-names>Y</given-names>
</string-name>
<italic>et al</italic> (<year>2011</year>) <article-title>Behavioral alterations associated with targeted disruption of exons 2 and 3 of the Disc1 gene in the mouse</article-title>. <source/>Hum Mol Genet
<volume>20</volume>: <fpage>4666</fpage>–<lpage>4683</lpage>
<pub-id pub-id-type="pmid">21903668</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0074">
<label>74</label>
<mixed-citation id="embr201642586-cit-0074" publication-type="journal">
<string-name>
<surname>Feng</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Mellor</surname>
<given-names>RH</given-names>
</string-name>, <string-name>
<surname>Bernstein</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Keller‐Peck</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Nguyen</surname>
<given-names>QT</given-names>
</string-name>, <string-name>
<surname>Wallace</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Nerbonne</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Lichtman</surname>
<given-names>JW</given-names>
</string-name>, <string-name>
<surname>Sanes</surname>
<given-names>JR</given-names>
</string-name> (<year>2000</year>) <article-title>Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP</article-title>. <source/>Neuron
<volume>28</volume>: <fpage>41</fpage>–<lpage>51</lpage>
<pub-id pub-id-type="pmid">11086982</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0075">
<label>75</label>
<mixed-citation id="embr201642586-cit-0075" publication-type="journal">
<string-name>
<surname>Alexopoulou</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Holt</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Medzhitov</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Flavell</surname>
<given-names>RA</given-names>
</string-name> (<year>2001</year>) <article-title>Recognition of double‐stranded RNA and activation of NF‐kappaB by Toll‐like receptor 3</article-title>. <source/>Nature
<volume>413</volume>: <fpage>732</fpage>–<lpage>738</lpage>
<pub-id pub-id-type="pmid">11607032</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0076">
<label>76</label>
<mixed-citation id="embr201642586-cit-0076" publication-type="journal">
<string-name>
<surname>Kopf</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Baumann</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Freer</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Freudenberg</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Lamers</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kishimoto</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Zinkernagel</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Bluethmann</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kohler</surname>
<given-names>G</given-names>
</string-name> (<year>1994</year>) <article-title>Impaired immune and acute‐phase responses in interleukin‐6‐deficient mice</article-title>. <source/>Nature
<volume>368</volume>: <fpage>339</fpage>–<lpage>342</lpage>
<pub-id pub-id-type="pmid">8127368</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0077">
<label>77</label>
<mixed-citation id="embr201642586-cit-0077" publication-type="journal">
<string-name>
<surname>Pasparakis</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Alexopoulou</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Episkopou</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Kollias</surname>
<given-names>G</given-names>
</string-name> (<year>1996</year>) <article-title>Immune and inflammatory responses in TNF alpha‐deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response</article-title>. <source/>J Exp Med
<volume>184</volume>: <fpage>1397</fpage>–<lpage>1411</lpage>
<pub-id pub-id-type="pmid">8879212</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0078">
<label>78</label>
<mixed-citation id="embr201642586-cit-0078" publication-type="journal">
<string-name>
<surname>Sholl</surname>
<given-names>DA</given-names>
</string-name> (<year>1953</year>) <article-title>Dendritic organization in the neurons of the visual and motor cortices of the cat</article-title>. <source/>J Anat
<volume>87</volume>: <fpage>387</fpage>–<lpage>406</lpage>
<pub-id pub-id-type="pmid">13117757</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0079">
<label>79</label>
<mixed-citation id="embr201642586-cit-0079" publication-type="journal">
<string-name>
<surname>Huang</surname>
<given-names>TN</given-names>
</string-name>, <string-name>
<surname>Chuang</surname>
<given-names>HC</given-names>
</string-name>, <string-name>
<surname>Chou</surname>
<given-names>WH</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>CY</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>HF</given-names>
</string-name>, <string-name>
<surname>Chou</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Hsueh</surname>
<given-names>YP</given-names>
</string-name> (<year>2014</year>) <article-title>Tbr1 haploinsufficiency impairs amygdalar axonal projections and results in cognitive abnormality</article-title>. <source/>Nat Neurosci
<volume>17</volume>: <fpage>240</fpage>–<lpage>247</lpage>
<pub-id pub-id-type="pmid">24441682</pub-id></mixed-citation>
</ref>
<ref id="embr201642586-bib-0080">
<label>80</label>
<mixed-citation id="embr201642586-cit-0080" publication-type="journal">
<string-name>
<surname>Chuang</surname>
<given-names>HC</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>TN</given-names>
</string-name>, <string-name>
<surname>Hsueh</surname>
<given-names>YP</given-names>
</string-name> (<year>2014</year>) <article-title>Neuronal excitation upregulates Tbr1, a high‐confidence risk gene of autism, mediating Grin2b expression in the adult brain</article-title>. <source/>Front Cell Neurosci
<volume>8</volume>: <fpage>280</fpage>
<pub-id pub-id-type="pmid">25309323</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>